Henrik Zetterberg, Laboratoriet för klinisk kemi

Basuppgifter

Arbete

CV

Article - Review (25)

1. Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: biological and clinical implications.

   Zetterberg Henrik.

   Reprod Biol Endocrinol. 2004:2:7.

   [Links: PMID: 14969589 | DOI länk][Source: PubMed®]
2. [There is a strong evidence that professional boxing results in chronic brain damage. The more head punches during a boxer's career, the bigger is the risk].

   Blennow Kaj, Popa Cornel, Rasulzada Abdullah, Minthon Lennart, Wallin Anders, Zetterberg Henrik.

   Lakartidningen 2005:102(36):2468-70, 2472-5.

   [Links: PMID: 16196432][Source: PubMed®]
3. The role of biomarkers in clinical trials for Alzheimer disease.

   Thal Leon J, Kantarci Kejal, Reiman Eric M, Klunk William E, Weiner Michael W, Zetterberg Henrik, Galasko Douglas, Praticò Domenico, Griffin Sue, Schenk Dale, Siemers Eric.

   Alzheimer Dis Assoc Disord 2006:20(1):6-15.

   [Links: PMID: 16493230 | DOI länk][Source: PubMed®]

   Web of Science® citations 89
4. Alzheimer's disease.

   Blennow Kaj, de Leon Mony J, Zetterberg Henrik.

   Lancet 2006:368(9533):387-403.

   [Links: PMID: 16876668 | DOI länk][Source: PubMed®]

   Web of Science® citations 666
5. Clinical proteomics in neurodegenerative disorders.

   Zetterberg H, Rüetschi U, Portelius E, Brinkmalm G, Andreasson U, Blennow K, Brinkmalm A.

   Acta Neurol Scand. 2008:118(1):1-11.

   [Links: PMID: 18279484 | DOI länk][Source: PubMed®]

   Web of Science® citations 25
6. Amyloid-related biomarkers for Alzheimer's disease.

   Andreasen Niels, Zetterberg Henrik.

   Curr Med Chem. 2008:15(8):766-71.

   [Links: PMID: 18393845][Source: PubMed®]

   Web of Science® citations 14
7. Targeted proteomics in Alzheimer's disease: focus on amyloid-beta.

   Portelius Erik, Zetterberg Henrik, Gobom Johan, Andreasson Ulf, Blennow Kaj.

   Expert review of proteomics 2008:5(2):225-37.

   [Links: PMID: 18466053 | DOI länk][Source: PubMed®]

   Web of Science® citations 18
8. Is plasma amyloid-beta a reliable biomarker for Alzheimer's disease?

   Zetterberg Henrik.

   Recent patents on CNS drug discovery 2008:3(2):109-11.

   [Links: PMID: 18537770][Source: PubMed®]
9. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.

   Hampel Harald, Bürger Katharina, Teipel Stefan J, Bokde Arun L W, Zetterberg Henrik, Blennow Kaj.

   Alzheimer's & dementia : the journal of the Alzheimer's Association 2008:4(1):38-48.

   [Links: PMID: 18631949 | DOI länk][Source: PubMed®]

   Web of Science® citations 111
10. CSF biomarkers for AD: their significance for clinical practice.

    Zetterberg Henrik, Mattsson Niklas, Blennow Kaj.

    Dementia Forum 2009:6

    [Source: User]
11. Alzheimer's disease and CSF biomarkers: key challenges for broad clinical applications.

    Mattsson Niklas, Zetterberg Henrik.

    Biomarkers in Medicine 2009:3

    [Source: User]
12. CSF biomarkers for AD: their significance for clinical practice.

    Zetterberg henrik, Mattsson Niklas, Blennow Kaj.

    Dementia Forum 2009:6

    [Source: User]
13. Levels of brain related proteins in cerebrospinal fluid: an aid in the differential diagnosis of parkinsonian disorders.

    Constantinescu Radu, Zetterberg Henrik, Holmberg Björn, Rosengren Lars.

    Parkinsonism Relat Disord. 2009:15(3):205-12.

    [Links: PMID: 18562238 | DOI länk][Source: PubMed®]

    Web of Science® citations 9
14. Synaptic retrogenesis and amyloid-beta in Alzheimer's disease.

    Wasling Pontus, Daborg Jonny, Riebe Ilse, Andersson My, Portelius Erik, Blennow Kaj, Hanse Eric, Zetterberg Henrik.

    J Alzheimers Dis. 2009:16(1):1-14.

    [Links: PMID: 19158416 | DOI länk][Source: PubMed®]

    Web of Science® citations 25
15. Update on amyloid-beta homeostasis markers for sporadic Alzheimer's disease.

    Zetterberg Henrik.

    Scand J Clin Lab Invest. 2009:69(1):18-21.

    [Links: PMID: 19199126 | DOI länk][Source: PubMed®]

    Web of Science® citations 1
16. [Biomarkers in cerebrospinal fluid and blood in memory complaints].

    Zetterberg Henrik, Andreasen Niels, Blennow Kaj.

    Lakartidningen 2009:106(20):1386-9.

    [Links: PMID: 19585836][Source: PubMed®]
17. Future screening for incipient Alzheimer's disease--the influence of prevalence on test performance.

    Mattsson Niklas, Zetterberg Henrik.

    Eur Neurol. 2009:62(4):200-3.

    [Links: PMID: 19602894 | DOI länk][Source: PubMed®]

    Web of Science® citations 4
18. Cerebrospinal fluid biomarkers for Alzheimer's disease.

    Blennow Kaj, Zetterberg Henrik.

    J Alzheimers Dis. 2009:18(2):413-7.

    [Links: PMID: 19661632 | DOI länk][Source: PubMed®]

    Web of Science® citations 20
19. CSF biomarkers: pinpointing Alzheimer pathogenesis.

    Mattsson Niklas, Blennow Kaj, Zetterberg Henrik.

    Ann N Y Acad Sci. 2009:1180:28-35.

    [Links: PMID: 19906258 | DOI länk][Source: PubMed®]

    Web of Science® citations 23
20. Cerebrospinal fluid biomarkers for vascular dementia.

    Mattsson Niklas, Zetterberg Henrik.

    Minerva Psichiatrica 2010:51

    [Source: User]
21. Inter-laboratory variations in CSF biomarkers for Alzheimer\'s disease: united we stand, divided we fall.

    Mattsson Niklas, Zetterberg Henrik, Blennow Kaj.

    Clin Chem Lab Med 2010:48

    [Source: User]

    Web of Science® citations 24
22. Total and phosphorylated tau protein as biological markers of Alzheimer's disease.

    Hampel Harald, Blennow Kaj, Shaw Leslie M, Hoessler Yvonne C, Zetterberg Henrik, Trojanowski John Q.

    Exp Gerontol. 2010:45(1):30-40.

    [Links: PMID: 19853650 | DOI länk][Source: PubMed®]
23. Biochemical markers in Alzheimer's disease clinical trials.

    Zetterberg Henrik, Mattsson Niklas, Shaw Les M, Blennow Kaj.

    Biomark Med 2010:4(1):91-8.

    [Links: PMID: 20387305][Source: PubMed®]

    Web of Science® citations 3
24. Problems associated with fluid biomarkers for Parkinson's disease.

    Nyhlén Jakob, Constantinescu Radu, Zetterberg Henrik.

    Biomark Med 2010:4(5):671-81.

    [Links: PMID: 20945980 | DOI länk][Source: PubMed]

    Web of Science® citations 4
25. Biomarker-based dissection of neurodegenerative diseases.

    Olsson Bob, Zetterberg Henrik, Hampel Harald, Blennow Kaj.

    Prog Neurobiol. 2011:95(4):520-34.

    [Links: PMID: 21524681 | DOI länk][Source: PubMed]

    Web of Science® citations 0

Article - Peer reviewed scientific (242)

1. Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection.

   Zetterberg H, Stenglein M, Jansson A, Ricksten A, Rymo L.

   J Gen Virol. 1999:80:457-66.

   [Links: PMID: 10073708][Source: PubMed®]

   Web of Science® citations 27
2. Promoter-proximal regulatory elements involved in oriP-EBNA1-independent and -dependent activation of the Epstein-Barr virus C promoter in B-lymphoid cell lines.

   Nilsson T, Zetterberg H, Wang Y C, Rymo L.

   J Virol. 2001:75(13):5796-811.

   [Links: PMID: 11390581 | DOI länk][Source: PubMed®]

   Web of Science® citations 26
3. Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos.

   Zetterberg Henrik, Regland Björn, Palmér Mona, Ricksten Anne, Palmqvist Lars, Rymo Lars, Arvanitis Demetrios A, Spandidos Demetrios A, Blennow Kaj.

   Eur J Hum Genet. 2002:10(2):113-8.

   [Links: PMID: 11938441 | DOI länk][Source: PubMed®]

   Web of Science® citations 77
4. Influence of the apolipoprotein E epsilon4 allele on human embryonic development.

   Zetterberg Henrik, Palmér Mona, Ricksten Anne, Poirier Judes, Palmqvist Lars, Rymo Lars, Zafiropoulos Alexander, Arvanitis Demetrios A, Spandidos Demetrios A, Blennow Kaj.

   Neurosci Lett. 2002:324(3):189-92.

   [Links: PMID: 12009520][Source: PubMed®]

   Web of Science® citations 21
5. The Epstein-Barr virus ZEBRA protein activates transcription from the early lytic F promoter by binding to a promoter-proximal AP-1-like site.

   Zetterberg Henrik, Jansson Ann, Rymo Lars, Chen Fu, Karlsson Ann, Klein Georg, Brodin Bertha.

   J Gen Virol. 2002:83:2007-14.

   [Links: PMID: 12124465][Source: PubMed®]

   Web of Science® citations 3
6. The transcobalamin codon 259 polymorphism influences the risk of human spontaneous abortion.

   Zetterberg H, Regland B, Palmér M, Rymo L, Zafiropoulos A, Arvanitis D A, Spandidos D A, Blennow K.

   Hum Reprod. 2002:17(12):3033-6.

   [Links: PMID: 12456598][Source: PubMed®]

   Web of Science® citations 19
7. No association between the MTHFR A1298C and transcobalamin C776G genetic polymorphisms and hyperhomocysteinemia in thrombotic disease.

   Zetterberg Henrik, Coppola Antonio, D'Angelo Armando, Palmér Mona, Rymo Lars, Blennow Kaj.

   Thromb Res. 2002:108(2-3):127-31.

   [Links: PMID: 12590948][Source: PubMed®]

   Web of Science® citations 12
8. Functional interaction of nuclear factor y and sp1 is required for activation of the epstein-barr virus C promoter.

   Boreström Cecilia, Zetterberg Henrik, Liff Kristian, Rymo Lars.

   J Virol. 2003:77(2):821-9.

   [Links: PMID: 12502798][Source: PubMed®]

   Web of Science® citations 19
9. Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia.

   Johansson Annica, Hampel Harald, Faltraco Frank, Buerger Katharina, Minthon Lennart, Bogdanovic Nenad, Sjögren Magnus, Zetterberg Henrik, Forsell Lena, Lilius Lena, Wahlund Lars Olov, Rymo Lars, Prince Jonathan, Blennow Kaj.

   Neurosci Lett. 2003:340(1):69-73.

   [Links: PMID: 12648761][Source: PubMed®]

   Web of Science® citations 21
10. The transcobalamin (TC) codon 259 genetic polymorphism influences holo-TC concentration in cerebrospinal fluid from patients with Alzheimer disease.

    Zetterberg Henrik, Nexö Ebba, Regland Björn, Minthon Lennart, Boson Roberta, Palmér Mona, Rymo Lars, Blennow Kaj.

    Clin Chem. 2003:49(7):1195-8.

    [Links: PMID: 12816923][Source: PubMed®]

    Web of Science® citations 22
11. Gene-gene interaction between fetal MTHFR 677C>T and transcobalamin 776C>G polymorphisms in human spontaneous abortion.

    Zetterberg Henrik, Zafiropoulos Alexis, Spandidos Demetrios A, Rymo Lars, Blennow Kaj.

    Hum Reprod. 2003:18(9):1948-50.

    [Links: PMID: 12923155][Source: PubMed®]

    Web of Science® citations 24
12. Cerebrospinal fluid markers for prediction of Alzheimer's disease.

    Zetterberg Henrik, Wahlund Lars-Olof, Blennow Kaj.

    Neurosci Lett. 2003:352(1):67-9.

    [Links: PMID: 14615052][Source: PubMed®]

    Web of Science® citations 84
13. Transcobalamin polymorphism and serum holo-transcobalamin in relation to Alzheimer's disease.

    McCaddon Andrew, Blennow Kaj, Hudson Peter, Hughes Alan, Barber Joan, Gray Rob, Davies Gareth, Williams John H H, Duguid Jennifer, Lloyd Alwyn, Tandy Steve, Everall Marge, Cattell Howard, McCaddon Anne, Ellis Dick, Palmer Mona, Bogdanovic Nenad, Gottfries Carl-Gerhard, Zetterberg Henrik, Rymo Lars, Regland Björn.

    Dement Geriatr Cogn Disord 2004:17(3):215-21.

    [Links: PMID: 14739547 | DOI länk][Source: PubMed®]

    Web of Science® citations 15
14. Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer's disease.

    Johansson Annica, Katzov Hagit, Zetterberg Henrik, Feuk Lars, Johansson Boo, Bogdanovic Nenad, Andreasen Niels, Lenhard Boris, Brookes Anthony J, Pedersen Nancy L, Blennow Kaj, Prince Jonathan A.

    Hum Genet. 2004:114(6):581-7.

    [Links: PMID: 15034781 | DOI länk][Source: PubMed®]

    Web of Science® citations 31
15. The methylenetetrahydrofolate reductase C677T polymorphism is a major determinant of coffee-induced increase of plasma homocysteine: a randomized placebo controlled study.

    Strandhagen Elisabeth, Zetterberg Henrik, Aires Nibia, Palmér Mona, Rymo Lars, Blennow Kaj, Landaas Sverre, Thelle Dag S.

    Int J Mol Med. 2004:13(6):811-5.

    [Links: PMID: 15138617][Source: PubMed®]

    Web of Science® citations 11
16. APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42.

    Prince J A, Zetterberg H, Andreasen N, Marcusson J, Blennow K.

    Neurology 2004:62(11):2116-8.

    [Links: PMID: 15184629][Source: PubMed®]

    Web of Science® citations 69
17. Multiple EBNA1-binding sites within oriPI are required for EBNA1-dependent transactivation of the Epstein-Barr virus C promoter.

    Zetterberg Henrik, Boreström Cecilia, Nilsson Tina, Rymo Lars.

    Int J Oncol. 2004:25(3):693-6.

    [Links: PMID: 15289871][Source: PubMed®]

    Web of Science® citations 6
18. Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease.

    Zetterberg Henrik, Andreasen Niels, Blennow Kaj.

    Neurosci Lett. 2004:367(2):194-6.

    [Links: PMID: 15331151 | DOI länk][Source: PubMed®]

    Web of Science® citations 33
19. The apolipoprotein E polymorphism and the cholesterol-raising effect of coffee.

    Strandhagen Elisabeth, Zetterberg Henrik, Aires Nibia, Palmér Mona, Rymo Lars, Blennow Kaj, Thelle Dag S.

    Lipids Health Dis 2004:3:26.

    [Links: PMID: 15571629 | DOI länk][Source: PubMed®]
20. Evaluation of factors of importance for clinical dementia diagnosis.

    Nagga Katarina, Garcia Jorge, Zetterberg Henrik, Blennow Kaj, Gottfries Johan, Marcusson Jan.

    Dement Geriatr Cogn Disord 2005:19(5):289-98.

    [Links: PMID: 15775718 | DOI länk][Source: PubMed®]

    Web of Science® citations 1
21. Functional interaction of Oct transcription factors with the family of repeats in Epstein-Barr virus oriP.

    Almqvist J, Zou J, Linderson Y, Borestrom C, Altiok E, Zetterberg H, Rymo L, Pettersson S, Ernberg I.

    J Gen Virol. 2005:86(Pt 5):1261-7.

    [Links: PMID: 15831936 | DOI länk][Source: PubMed®]

    Web of Science® citations 7
22. [New investigations in suspected Creutzfeldt-Jakob disease. Analysis of 14-3-3 protein and T-tau in cerebrospinal fluid for safer diagnosis].

    Zetterberg Henrik, Hammarin Anna-Lena, Nilsson Petra, Andersson Elsa, Lind Börje, Blennow Kaj.

    Lakartidningen 2005:102(12-13):956-8, 960-1.

    [Links: PMID: 15887642][Source: PubMed®]
23. Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF.

    Rüetschi Ulla, Zetterberg Henrik, Podust Vladimir N, Gottfries Johan, Li Susann, Hviid Simonsen Anja, McGuire James, Karlsson Mats, Rymo Lars, Davies Huw, Minthon Lennart, Blennow Kaj.

    Exp Neurol. 2005:196(2):273-81.

    [Links: PMID: 16154129 | DOI länk][Source: PubMed®]

    Web of Science® citations 53
24. Characterization of EBV-transformed B-cells established from an individual homozygously mutated (G329A) in the FUT7 alpha1,3-fucosyltransferase gene.

    Bengtson Per, Zetterberg Henrik, Mellberg Tomas, Påhlsson Peter, Larson Göran.

    Scandinavian Journal of Immunology 2005:62(3):8.

    [Links: PMID: 16179012 | DOI länk | Weblänk][Source: PubMed®]

    Web of Science® citations 0
25. Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease.

    Johansson Annica, Zetterberg Henrik, Hampel Harald, Buerger Katharina, Prince Jonathan, Minthon Lennart, Wahlund Lars Olov, Blennow Kaj.

    Dement Geriatr Cogn Disord 2005:20(6):367-74.

    [Links: PMID: 16192727 | DOI länk][Source: PubMed®]

    Web of Science® citations 11
26. Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease.

    Blennow Kaj, Johansson Annica, Zetterberg Henrik.

    Int J Mol Med. 2005:16(6):1147-9.

    [Links: PMID: 16273298][Source: PubMed®]

    Web of Science® citations 16
27. Methylenetetrahydrofolate reductase genetic polymorphisms in patients with cataract.

    Zetterberg Madeleine, Tasa Gunnar, Prince Jonathan A, Palmér Mona, Juronen Erkki, Veromann Siiri, Teesalu Pait, Karlsson Jan-Olof, Blennow Kaj, Zetterberg Henrik.

    Am J Ophthalmol. 2005:140(5):932-4.

    [Links: PMID: 16310481 | DOI länk][Source: PubMed®]

    Web of Science® citations 4
28. Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation.

    Rüetschi Ulla, Rosén Asa, Karlsson Gösta, Zetterberg Henrik, Rymo Lars, Hagberg Henrik, Jacobsson Bo.

    J Proteome Res. 2005:4(6):2236-42.

    [Links: PMID: 16335971 | DOI länk][Source: PubMed®]

    Web of Science® citations 52
29. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.

    Johansson Annica, Zetterberg Henrik, Håkansson Anna, Nissbrandt Hans, Blennow Kaj.

    Neurodegener Dis 2005:2(1):28-35.

    [Links: PMID: 16909000 | DOI länk][Source: PubMed®]
30. Zebrafish lacking Alzheimer presenilin enhancer 2 (Pen-2) demonstrate excessive p53-dependent apoptosis and neuronal loss.

    Campbell William A, Yang Hongwei, Zetterberg Henrik, Baulac Stéphanie, Sears Jacqueline A, Liu Tianming, Wong Stephen T C, Zhong Tao P, Xia Weiming.

    J Neurochem. 2006:96(5):1423-40.

    [Links: PMID: 16464238 | DOI länk][Source: PubMed®]

    Web of Science® citations 58
31. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.

    Hansson Oskar, Zetterberg Henrik, Buchhave Peder, Londos Elisabet, Blennow Kaj, Minthon Lennart.

    Lancet neurology 2006:5(3):228-34.

    [Links: PMID: 16488378 | DOI länk][Source: PubMed®]

    Web of Science® citations 436
32. The cytosolic loop of the gamma-secretase component presenilin enhancer 2 protects zebrafish embryos from apoptosis.

    Zetterberg Henrik, Campbell William A, Yang Hong Wei, Xia Weiming.

    J Biol Chem. 2006:281(17):11933-9.

    [Links: PMID: 16507571 | DOI länk][Source: PubMed®]

    Web of Science® citations 16
33. Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry.

    Portelius Erik, Westman-Brinkmalm Ann, Zetterberg Henrik, Blennow Kaj.

    J Proteome Res. 2006:5(4):1010-6.

    [Links: PMID: 16602710 | DOI länk][Source: PubMed®]

    Web of Science® citations 43
34. The taqI DRD2 A1 allele is associated with alcohol-dependence although its effect size is small.

    Berggren Ulf, Fahlke Claudia, Aronsson Erik, Karanti Aikaterini, Eriksson Matts, Blennow Kaj, Thelle Dag, Zetterberg Henrik, Balldin Jan.

    Alcohol Alcohol. 2006:41(5):479-85.

    [Links: PMID: 16751215 | DOI länk][Source: PubMed®]

    Web of Science® citations 23
35. Neurochemical aftermath of amateur boxing.

    Zetterberg Henrik, Hietala M Albert, Jonsson Michael, Andreasen Niels, Styrud Ewa, Karlsson Ingvar, Edman Ake, Popa Cornel, Rasulzada Abdullah, Wahlund Lars-Olof, Mehta Pankaj D, Rosengren Lars, Blennow Kaj.

    Archives of Neurology 2006

    [Links: PMID: 16966505][Source: PubMed®]

    Web of Science® citations 46
36. An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid.

    Portelius Erik, Zetterberg Henrik, Andreasson Ulf, Brinkmalm Gunnar, Andreasen Niels, Wallin Anders, Westman-Brinkmalm Ann, Blennow Kaj.

    Neurosci Lett. 2006:409(3):215-9.

    [Links: PMID: 17049739 | DOI länk][Source: PubMed®]

    Web of Science® citations 41
37. Cystatin C in cerebrospinal fluid and multiple sclerosis.

    Hansson Sara F, Simonsen Anja Hviid, Zetterberg Henrik, Andersen Oluf, Haghighi Sara, Fagerberg Inger, Andréasson Ulf, Westman-Brinkmalm Ann, Wallin Anders, Rüetschi Ulla, Blennow Kaj.

    Ann Neurol. 2007:62(2):193-6; discussion 20.

    [Links: PMID: 16900522 | DOI länk][Source: PubMed®]

    Web of Science® citations 18
38. Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older women.

    Gustafson Deborah R, Skoog Ingmar, Rosengren Lars, Zetterberg Henrik, Blennow Kaj.

    J Neurol Neurosurg Psychiatr. 2007:78(5):461-4.

    [Links: PMID: 17098843 | DOI länk][Source: PubMed®]

    Web of Science® citations 45
39. Elevated cerebrospinal fluid F2-isoprostane levels indicating oxidative stress in healthy siblings of multiple sclerosis patients.

    Mattsson Niklas, Haghighi Sara, Andersen Oluf, Yao Yuemang, Rosengren Lars, Blennow Kaj, Praticò Domenico, Zetterberg Henrik.

    Neurosci Lett. 2007:414(3):233-6.

    [Links: PMID: 17227694 | DOI länk][Source: PubMed®]

    Web of Science® citations 10
40. Amyloid beta1-40 quantification in CSF: comparison between chromatographic and immunochemical methods.

    Simonsen A H, Hansson S F, Ruetschi U, McGuire J, Podust V N, Davies H A, Mehta P, Waldemar G, Zetterberg H, Andreasen N, Wallin A, Blennow K.

    Dement Geriatr Cogn Disord 2007:23(4):246-50.

    [Links: PMID: 17310122 | DOI länk][Source: PubMed®]

    Web of Science® citations 20
41. Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment.

    Simonsen Anja H, McGuire James, Hansson Oskar, Zetterberg Henrik, Podust Vladimir N, Davies Huw A, Waldemar Gunhild, Minthon Lennart, Blennow Kaj.

    Arch Neurol. 2007:64(3):366-70.

    [Links: PMID: 17353378 | DOI länk][Source: PubMed®]

    Web of Science® citations 57
42. Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.

    Hansson Oskar, Zetterberg Henrik, Buchhave Peder, Andreasson Ulf, Londos Elisabet, Minthon Lennart, Blennow Kaj.

    Dement Geriatr Cogn Disord 2007:23(5):316-20.

    [Links: PMID: 17374949 | DOI länk][Source: PubMed®]

    Web of Science® citations 68
43. Cerebrospinal fluid protein reactions during non-neurological surgery.

    Anckarsäter R, Vasic N, Jidéus L, Kristiansson M, Zetterberg H, Blennow K, Anckarsäter H.

    Acta Neurol Scand. 2007:115(4):254-9.

    [Links: PMID: 17376123 | DOI länk][Source: PubMed®]

    Web of Science® citations 9
44. Longitudinal stability of CSF biomarkers in Alzheimer's disease.

    Blennow Kaj, Zetterberg Henrik, Minthon Lennart, Lannfelt Lars, Strid Stig, Annas Peter, Basun Hans, Andreasen Niels.

    Neurosci Lett. 2007:419(1):18-22.

    [Links: PMID: 17482358 | DOI länk][Source: PubMed®]

    Web of Science® citations 65
45. No neurochemical evidence for brain injury caused by heading in soccer.

    Zetterberg Henrik, Jonsson Michael, Rasulzada Abdullah, Popa Cornel, Styrud Ewa, Hietala Max Albert, Rosengren Lars, Wallin Anders, Blennow Kaj.

    British journal of sports medicine 2007:41(9):574-7.

    [Links: PMID: 17496068 | DOI länk][Source: PubMed®]

    Web of Science® citations 10
46. Apolipoprotein E polymorphisms in patients with primary open-angle glaucoma.

    Zetterberg Madeleine, Tasa Gunnar, Palmér Mona Seibt, Juronen Erkki, Teesalu Pait, Blennow Kaj, Zetterberg Henrik.

    Am J Ophthalmol. 2007:143(6):1059-60.

    [Links: PMID: 17524782 | DOI länk][Source: PubMed®]

    Web of Science® citations 8
47. Methylenetetrahydrofolate reductase genetic polymorphisms in patients with primary open-angle glaucoma.

    Zetterberg Madeleine, Tasa Gunnar, Palmér Mona Seibt, Juronen Erkki, Toover Egle, Blennow Kaj, Zetterberg Henrik.

    Ophthalmic Genet. 2007:28(2):47-50.

    [Links: PMID: 17558844 | DOI länk][Source: PubMed®]

    Web of Science® citations 6
48. Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease.

    Andersson Malin E, Sjölander Annica, Andreasen Niels, Minthon Lennart, Hansson Oskar, Bogdanovic Nenad, Jern Christina, Jood Katarina, Wallin Anders, Blennow Kaj, Zetterberg Henrik.

    Int J Mol Med. 2007:20(2):233-9.

    [Links: PMID: 17611642][Source: PubMed®]

    Web of Science® citations 9
49. Variability in the kinesin light chain 1 gene may influence risk of age-related cataract.

    Andersson Malin E, Zetterberg Madeleine, Tasa Gunnar, Seibt-Palmér Mona, Juronen Erkki, Teesalu Pait, Blennow Kaj, Zetterberg Henrik.

    Mol Vis. 2007:13:993-6.

    [Links: PMID: 17653041][Source: PubMed®]

    Web of Science® citations 8
50. Association between thyroid hormone levels and monoaminergic neurotransmission during surgery.

    Anckarsäter Rolf, Zetterberg Henrik, Blennow Kaj, Anckarsäter Henrik.

    Psychoneuroendocrinology 2007:32(8):1138-43.

    [Links: PMID: 17826921 | DOI länk][Source: PubMed®]

    Web of Science® citations 6
51. Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype.

    Zetterberg H, Jacobsson J, Rosengren L, Blennow K, Andersen P M.

    Eur J Neurol. 2007:14(12):1329-33.

    [Links: PMID: 17903209 | DOI länk][Source: PubMed®]

    Web of Science® citations 29
52. Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry.

    Portelius Erik, Tran Ai Jun, Andreasson Ulf, Persson Rita, Brinkmalm Gunnar, Zetterberg Henrik, Blennow Kaj, Westman-Brinkmalm Ann.

    J Proteome Res. 2007:6(11):4433-9.

    [Links: PMID: 17927230 | DOI länk][Source: PubMed®]

    Web of Science® citations 35
53. Cerebrospinal fluid concentrations of peptides derived from chromogranin B and secretogranin II are decreased in multiple sclerosis.

    Mattsson Niklas, Rüetschi Ulla, Podust Vladimir N, Stridsberg Mats, Li Susann, Andersen Oluf, Haghighi Sara, Blennow Kaj, Zetterberg Henrik.

    J Neurochem. 2007:103(5):1932-9.

    [Links: PMID: 17953655 | DOI länk][Source: PubMed®]

    Web of Science® citations 9
54. Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years.

    Zetterberg Henrik, Pedersen Mona, Lind Karin, Svensson Maria, Rolstad Sindre, Eckerström Carl, Syversen Steinar, Mattsson Ulla-Britt, Ysander Christina, Mattsson Niklas, Nordlund Arto, Vanderstichele Hugo, Vanmechelen Eugeen, Jonsson Michael, Edman Ake, Blennow Kaj, Wallin Anders.

    J Alzheimers Dis. 2007:12(3):255-60.

    [Links: PMID: 18057559][Source: PubMed®]

    Web of Science® citations 48
55. Identification of a beta-amyloid-binding plasma protein, LRP1: implications for biomarker research and therapy in Alzheimer's disease.

    Zetterberg Henrik.

    Biomark Med 2007:1(3):347-8.

    [Links: PMID: 20477378 | DOI länk][Source: PubMed]

    Web of Science® citations 0
56. Aspects of beta-amyloid as a biomarker for Alzheimer's disease.

    Andreasson Ulf, Portelius Erik, Andersson Malin E, Blennow Kaj, Zetterberg Henrik.

    Biomark Med 2007:1(1):59-78.

    [Links: PMID: 20477461 | DOI länk][Source: PubMed®]

    Web of Science® citations 34
57. Novel cerebrospinal fluid biomarkers of axonal degeneration in frontotemporal dementia.

    Mattsson Niklas, Rüetschi Ulla, Pijnenburg Yolande, Blankenstein Marinus, Podust Vladimir, Li Susann, Fagerberg Inger, Rosengren Lars, Blennow Kaj, Zetterberg Henrik.

    Molecular Medicine Reports 2008:1

    [Source: User]

    Web of Science® citations 4
58. Hypertension in spontaneously hypertensive rats occurs despite low plasma levels of homocysteine.

    Kondziella D, Zetterberg H, Haugen E, Fu M.

    Physiol Res 2008:57(3):487-90.

    [Links: PMID: 17298201][Source: PubMed®]

    Web of Science® citations 2
59. Association of complement factor H Y402H gene polymorphism with Alzheimer's disease.

    Zetterberg Madeleine, Landgren S, Andersson M, Palmér Mona, Gustafson Deborah, Skoog Ingmar, Minthon Lennart, Thelle Dag, Wallin Anders, Bogdanovic N, Andreasen Nils, Blennow Kaj, Zetterberg Henrik.

    Am J Med Genet B Neuropsychiatr Genet. 2008:147(6):720-6.

    [Links: PMID: 18163432 | DOI länk][Source: PubMed®]

    Web of Science® citations 15
60. Non-neurological surgery results in a neurochemical stress response.

    Anckarsäter R, Zetterberg H, Månsson J-E, Blennow K, Anckarsäter H.

    Journal of neural transmission (Vienna, Austria : 1996) 2008:115(3):397-9.

    [Links: PMID: 18250956 | DOI länk][Source: PubMed®]

    Web of Science® citations 0
61. Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease.

    Kadir Ahmadul, Andreasen Niels, Almkvist Ove, Wall Anders, Forsberg Anton, Engler Henry, Hagman Göran, Lärksäter Marie, Winblad Bengt, Zetterberg Henrik, Blennow Kaj, Långström Bengt, Nordberg Agneta.

    Ann Neurol. 2008:63(5):621-31.

    [Links: PMID: 18300284 | DOI länk][Source: PubMed®]

    Web of Science® citations 49
62. Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.

    Höglund K, Hansson O, Buchhave P, Zetterberg H, Lewczuk P, Londos E, Blennow K, Minthon L, Wiltfang J.

    Neuro-degenerative diseases 2008:5(5):268-76.

    [Links: PMID: 18309230 | DOI länk][Source: PubMed®]

    Web of Science® citations 6
63. Characterization of tau in cerebrospinal fluid using mass spectrometry.

    Portelius Erik, Hansson Sara F, Tran Ai Jun, Zetterberg Henrik, Grognet Pierre, Vanmechelen Eugeen, Höglund Kina, Brinkmalm Gunnar, Westman-Brinkmalm Ann, Nordhoff Eckhard, Blennow Kaj, Gobom Johan.

    J Proteome Res. 2008:7(5):2114-20.

    [Links: PMID: 18351740 | DOI länk][Source: PubMed®]

    Web of Science® citations 13
64. Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization.

    Klyubin Igor, Betts Vicki, Welzel Alfred T, Blennow Kaj, Zetterberg Henrik, Wallin Anders, Lemere Cynthia A, Cullen William K, Peng Ying, Wisniewski Thomas, Selkoe Dennis J, Anwyl Roger, Walsh Dominic M, Rowan Michael J.

    J Neurosci. 2008:28(16):4231-7.

    [Links: PMID: 18417702 | DOI länk][Source: PubMed®]

    Web of Science® citations 109
65. Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.

    Hansson Oskar, Zetterberg Henrik, Vanmechelen Eugeen, Vanderstichele Hugo, Andreasson Ulf, Londos Elisabet, Wallin Anders, Minthon Lennart, Blennow Kaj.

    Neurobiol Aging 2008

    [Links: PMID: 18486992 | DOI länk][Source: PubMed®]
66. Hyperphosphorylation of tau protein in superficial CNS siderosis.

    Kondziella Daniel, Zetterberg Henrik.

    J Neurol Sci. 2008:273(1-2):130-2.

    [Links: PMID: 18617192 | DOI länk][Source: PubMed®]

    Web of Science® citations 2
67. Biological CSF Markers of Alzheimer's Disease.

    Zetterberg Henrik, Blennow Kaj.

    Handb Clin Neurol 2008:89:261-8.

    [Links: PMID: 18631750 | DOI länk][Source: PubMed®]
68. Association of APOE with age at onset of sporadic amyotrophic lateral sclerosis.

    Zetterberg Henrik, Jacobsson Johan, Rosengren Lars, Blennow Kaj, Andersen Peter M.

    J Neurol Sci. 2008:273(1-2):67-9.

    [Links: PMID: 18656208 | DOI länk][Source: PubMed®]

    Web of Science® citations 9
69. Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial.

    Lannfelt Lars, Blennow Kaj, Zetterberg Henrik, Batsman Stellan, Ames David, Harrison John, Masters Colin L, Targum Steve, Bush Ashley I, Murdoch Ross, Wilson Janet, Ritchie Craig W;
    PBT2-201-EURO study group.

    Lancet neurology 2008:7(9):779-86.

    [Links: PMID: 18672400 | DOI länk][Source: PubMed®]
70. Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease.

    Zetterberg Henrik, Andreasson Ulf, Hansson Oskar, Wu Guoxin, Sankaranarayanan Sethu, Andersson Malin E, Buchhave Peder, Londos Elisabet, Umek Robert M, Minthon Lennart, Simon Adam J, Blennow Kaj.

    Arch Neurol. 2008:65(8):1102-7.

    [Links: PMID: 18695061 | DOI länk][Source: PubMed®]

    Web of Science® citations 44
71. Association of pro-ghrelin and GHS-R1A gene polymorphisms and haplotypes with heavy alcohol use and body mass.

    Landgren Sara, Jerlhag Elisabet, Zetterberg Henrik, Gonzalez-Quintela Arturo, Campos Joaquin, Olofsson Ulrica, Nilsson Staffan, Blennow Kaj, Engel Jörgen A.

    Alcohol Clin Exp Res. 2008:32(12):2054-61.

    [Links: PMID: 18828808 | DOI länk][Source: PubMed®]

    Web of Science® citations 25
72. Soluble TNF receptors are associated with Abeta metabolism and conversion to dementia in subjects with mild cognitive impairment.

    Buchhave Peder, Zetterberg Henrik, Blennow Kaj, Minthon Lennart, Janciauskiene Sabina, Hansson Oskar.

    Neurobiol Aging 2008

    [Links: PMID: 19070941 | DOI länk][Source: PubMed®]
73. Study bridges the gap between advanced mass spectrometry and immuno-based multiplex assays.

    Zetterberg Henrik.

    Biomark Med 2008:2(3):219.

    [Links: PMID: 20477410 | DOI länk][Source: PubMed]
74. Novel cerebrospinal fluid biomarkers of axonal degeneration in frontotemporal dementia.

    Mattsson Niklas, Rüetschi Ulla, Pijnenburg Yolande A L, Blankenstein Marinus A, Podust Vladimir N, Li Susann, Fagerberg Inger, Rosengren Lars, Blennow Kaj, Zetterberg Henrik.

    Mol Med Report 2008:1(5):757-61.

    [Links: PMID: 21479482 | DOI länk][Source: PubMed]

    Web of Science® citations 4
75. Cerebrospinal fluid biomarker of white matter lesions-cross-sectional results form the LADIS study.

    Jonsson Michael, Zetterberg Henrik, van Straaten E, Lind Karin, Syversen Steinar, Edman Åke, Blennow Kaj, Rosengren Lars, Pantoni Leonardo, Inzitari D, Wallin Anders.

    European journal of neurology : the official journal of the European Federation of Neurological Societies 2009:17

    [Source: User]

    Web of Science® citations 7
76. Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease.

    Hansson Oskar, Buchhave Peder, Zetterberg Henrik, Blennow Kaj, Minthon Lennart, Warkentin Siegbert.

    Neurobiol Aging 2009:30(2):165-73.

    [Links: PMID: 17646035 | DOI länk][Source: PubMed®]

    Web of Science® citations 23
77. The PPAR-alpha gene in Alzheimer's disease: lack of replication of earlier association.

    Sjölander Annica, Minthon Lennart, Bogdanovic Nenad, Wallin Anders, Zetterberg Henrik, Blennow Kaj.

    Neurobiol Aging 2009:30(4):666-8.

    [Links: PMID: 17850927 | DOI länk][Source: PubMed®]

    Web of Science® citations 2
78. CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies.

    Boström Fredrik, Hansson Oskar, Gerhardsson Lars, Lundh Thomas, Minthon Lennart, Stomrud Erik, Zetterberg Henrik, Londos Elisabet.

    Neurobiol Aging 2009:30(8):1265-71.

    [Links: PMID: 18191875 | DOI länk][Source: PubMed®]
79. Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease.

    Buchhave Peder, Janciauskiene Sabina, Zetterberg Henrik, Blennow Kaj, Minthon Lennart, Hansson Oskar.

    Neurosci Lett. 2009:450(1):56-9.

    [Links: PMID: 18996438 | DOI länk][Source: PubMed®]

    Web of Science® citations 8
80. Elevated cerebrospinal fluid levels of prostaglandin E2 and 15-(S)-hydroxyeicosatetraenoic acid in multiple sclerosis.

    Mattsson N, Yaong M, Rosengren L, Blennow K, Månsson J-E, Andersen O, Zetterberg H, Haghighi S, Zho I, Pratico D.

    J Intern Med. 2009:265(4):459-64.

    [Links: PMID: 19019188 | DOI länk][Source: PubMed®]

    Web of Science® citations 2
81. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?

    Ohrfelt Annika, Grognet Pierre, Andreasen Niels, Wallin Anders, Vanmechelen Eugeen, Blennow Kaj, Zetterberg Henrik.

    Neurosci Lett. 2009:450(3):332-5.

    [Links: PMID: 19022350 | DOI länk][Source: PubMed®]

    Web of Science® citations 35
82. Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.

    Mattsson N, Axelsson M, Haghighi S, Malmeström C, Wu G, Anckarsäter R, Sankaranarayanan S, Andreasson U, Fredrikson S, Gundersen A, Johnsen L, Fladby T, Tarkowski A, Trysberg E, Wallin A, Anckarsäter H, Lycke J, Andersen O, Simon A J, Blennow K, Zetterberg H.

    Mult Scler. 2009:15(4):448-54.

    [Links: PMID: 19153172 | DOI länk][Source: PubMed®]

    Web of Science® citations 17
83. Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury.

    Marklund Niklas, Blennow Kaj, Zetterberg Henrik, Ronne-Engström Elisabeth, Enblad Per, Hillered Lars.

    J Neurosurg. 2009:110(6):1227-37.

    [Links: PMID: 19216653 | DOI länk][Source: PubMed®]

    Web of Science® citations 14
84. Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease.

    Brys Miroslaw, Glodzik Lidia, Mosconi Lisa, Switalski Remigiusz, De Santi Susan, Pirraglia Elizabeth, Rich Kenneth, Kim Byeong C, Mehta Pankaj, Zinkowski Ray, Pratico Domenico, Wallin Anders, Zetterberg Henrik, Tsui Wai H, Rusinek Henry, Blennow Kaj, de Leon Mony J.

    J Alzheimers Dis. 2009:16(2):351-62.

    [Links: PMID: 19221425 | DOI länk][Source: PubMed®]

    Web of Science® citations 18
85. Reduced levels of amyloid-beta-binding proteins in cerebrospinal fluid from Alzheimer's disease patients.

    Hansson Sara F, Andréasson Ulf, Wall Mariann, Skoog Ingmar, Andreasen Niels, Wallin Anders, Zetterberg Henrik, Blennow Kaj.

    J Alzheimers Dis. 2009:16(2):389-97.

    [Links: PMID: 19221428 | DOI länk][Source: PubMed®]

    Web of Science® citations 20
86. Biomarkers in relation to cognitive reserve in patients with mild cognitive impairment--proof of concept.

    Rolstad S, Nordlund A, Eckerström C, Gustavsson M H, Zetterberg H, Wallin A.

    Dement Geriatr Cogn Disord 2009:27(2):194-200.

    [Links: PMID: 19225233 | DOI länk][Source: PubMed®]

    Web of Science® citations 10
87. Identification of novel APP/Abeta isoforms in human cerebrospinal fluid.

    Portelius Erik, Brinkmalm Gunnar, Tran Ai Jun, Zetterberg Henrik, Westman-Brinkmalm Ann, Blennow Kaj.

    Neuro-degenerative diseases 2009:6(3):87-94.

    [Links: PMID: 19229112 | DOI länk][Source: PubMed®]

    Web of Science® citations 14
88. Evolution of Abeta42 and Abeta40 Levels and Abeta42/Abeta40 Ratio in Plasma during Progression of Alzheimer's Disease: A Multicenter Assessment.

    Blennow K, De Meyer G, Hansson O, Minthon L, Wallin A, Zetterberg H, Lewczuk P, Vanderstichele H, Vanmechelen E, Kornhuber J, Wiltfang J;
    KND-Study Group.

    The journal of nutrition, health & aging 2009:13(3):205-8.

    [Links: PMID: 19262954][Source: PubMed®]

    Web of Science® citations 8
89. Proteomics/peptidomics tools to find CSF biomarkers for neurodegenerative diseases.

    Westman-Brinkmalm Ann, Ruetschi Ulla, Portelius Erik, Andreasson Ulf, Brinkmalm Gunnar, Karlsson Gosta, Hansson Sara, Zetterberg Henrik, Blennow Kaj.

    Front Biosci. 2009:14:1793-806.

    [Links: PMID: 19273163][Source: PubMed®]

    Web of Science® citations 16
90. Thrombocytopenia in early alcohol withdrawal is associated with development of delirium tremens or seizures.

    Berggren Ulf, Fahlke Claudia, Berglund Kristina J, Blennow Kaj, Zetterberg Henrik, Balldin Jan.

    Alcohol Alcohol. 2009:44(4):382-6.

    [Links: PMID: 19293148 | DOI länk][Source: PubMed®]

    Web of Science® citations 4
91. Use of CSF biomarkers in Alzheimer's disease clinical trials.

    Blennow K, Zetterberg H.

    J Nutr Health Aging 2009:13(4):358-61.

    [Links: PMID: 19300880][Source: PubMed®]

    Web of Science® citations 9
92. The szilard hypothesis on the nature of aging revisited.

    Zetterberg Henrik, Båth Magnus, Zetterberg Madeleine, Bernhardt Peter, Hammarsten Ola.

    Genetics 2009:182(1):3-9.

    [Links: PMID: 19403867 | DOI länk][Source: PubMed®]

    Web of Science® citations 1
93. Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype.

    Blom Elin S, Giedraitis Vilmantas, Zetterberg Henrik, Fukumoto Hiroaki, Blennow Kaj, Hyman Bradley T, Irizarry Michael C, Wahlund Lars-Olof, Lannfelt Lars, Ingelsson Martin.

    Dement Geriatr Cogn Disord 2009:27(5):458-64.

    [Links: PMID: 19420940 | DOI länk][Source: PubMed®]

    Web of Science® citations 17
94. B-type natriuretic peptide plasma levels are elevated in subcortical vascular dementia.

    Kondziella Daniel, Göthlin Mattias, Fu Michael, Zetterberg Henrik, Wallin Anders.

    Neuroreport 2009:20(9):825-7.

    [Links: PMID: 19424098 | DOI länk][Source: PubMed®]

    Web of Science® citations 4
95. Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI).

    Buerger Katharina, Frisoni Giovanni, Uspenskaya Olga, Ewers Michael, Zetterberg Henrik, Geroldi Cristina, Binetti Giuliano, Johannsen Peter, Rossini Paolo Maria, Wahlund Lars-Olof, Vellas Bruno, Blennow Kaj, Hampel Harald.

    Exp Gerontol. 2009:44(9):579-85.

    [Links: PMID: 19539742 | DOI länk][Source: PubMed®]
96. Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid.

    Portelius Erik, Brinkmalm Gunnar, Tran Aijun, Andreasson Ulf, Zetterberg Henrik, Westman-Brinkmalm Ann, Blennow Kaj, Ohrfelt Annika.

    Exp Neurol. 2009

    [Links: PMID: 19559702 | DOI länk][Source: PubMed®]
97. A novel pathway for amyloid precursor protein processing.

    Portelius Erik, Price Eric, Brinkmalm Gunnar, Stiteler Mark, Olsson Maria, Persson Rita, Westman-Brinkmalm Ann, Zetterberg Henrik, Simon Adam J, Blennow Kaj.

    Neurobiol Aging 2009

    [Links: PMID: 19604603 | DOI länk][Source: PubMed®]
98. Longitudinal study of CSF biomarkers in patients with Alzheimer's disease.

    Buchhave Peder, Blennow Kaj, Zetterberg Henrik, Stomrud Erik, Londos Elisabet, Andreasen Niels, Minthon Lennart, Hansson Oskar.

    PLoS ONE 2009:4(7):e6294.

    [Links: PMID: 19609443 | DOI länk][Source: PubMed®]

    Web of Science® citations 15
99. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

    Mattsson Niklas, Zetterberg Henrik, Hansson Oskar, Andreasen Niels, Parnetti Lucilla, Jonsson Michael, Herukka Sanna-Kaisa, van der Flier Wiesje M, Blankenstein Marinus A, Ewers Michael, Rich Kenneth, Kaiser Elmar, Verbeek Marcel, Tsolaki Magda, Mulugeta Ezra, Rosén Erik, Aarsland Dag, Visser Pieter Jelle, Schröder Johannes, Marcusson Jan, de Leon Mony, Hampel Harald, Scheltens Philip, Pirttilä Tuula, Wallin Anders, Jönhagen Maria Eriksdotter, Minthon Lennart, Winblad Bengt, Blennow Kaj.

    JAMA 2009:302(4):385-93.

    [Links: PMID: 19622817 | DOI länk][Source: PubMed®]

    Web of Science® citations 192
100. Sustained release of neuron-specific enolase to serum in amateur boxers.

     Zetterberg Henrik, Tanriverdi Fatih, Unluhizarci Kursad, Selcuklu Ahmet, Kelestimur Fahrettin, Blennow Kaj.

     Brain Inj 2009:23(9):723-6.

     [Links: PMID: 19636997 | DOI länk][Source: PubMed®]

     Web of Science® citations 5
101. Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical parkinsonian disorders.

     Constantinescu Radu, Rosengren Lars, Johnels Bo, Zetterberg Henrik, Holmberg Bjorn.

     Parkinsonism Relat Disord. 2009

     [Links: PMID: 19647470 | DOI länk][Source: PubMed®]

     Web of Science® citations 3
102. Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity.

     Sämgård Kajsa, Zetterberg Henrik, Blennow Kaj, Hansson Oskar, Minthon Lennart, Londos Elisabet.

     Int J Geriatr Psychiatry 2009

     [Links: PMID: 19650161 | DOI länk][Source: PubMed®]

     Web of Science® citations 6
103. Effects of Memantine on Cerebrospinal Fluid Biomarkers of Neurofibrillary Pathology.

     Glodzik Lidia, De Santi Susan, Rich Kenneth E, Brys Miroslaw, Pirraglia Elizabeth, Mistur Rachel, Switalski Remigiusz, Mosconi Lisa, Sadowski Martin, Zetterberg Henrik, Blennow Kaj, de Leon Mony J.

     J Alzheimers Dis. 2009

     [Links: PMID: 19661628 | DOI länk][Source: PubMed®]

     Web of Science® citations 1
104. Cognitive reserve in relation to abeta42 in patients converting from MCI to dementia - a follow-up report.

     Rolstad S, Nordlund A, Eckerström C, Gustavsson M H, Zetterberg H, Wallin A.

     Dement Geriatr Cogn Disord 2009:28(2):110-5.

     [Links: PMID: 19684400 | DOI länk][Source: PubMed®]

     Web of Science® citations 3
105. Association of nAChR gene haplotypes with heavy alcohol use and body mass.

     Landgren Sara, Engel Jörgen A, Andersson Malin E, Gonzalez-Quintela Arturo, Campos Joaquin, Nilsson Staffan, Zetterberg Henrik, Blennow Kaj, Jerlhag Elisabet.

     Brain Res. 2009

     [Links: PMID: 19698703 | DOI länk][Source: PubMed®]
106. Biological markers of amyloid beta-related mechanisms in Alzheimer's disease.

     Hampel Harald, Shen Yong, Walsh Dominic M, Aisen Paul, Shaw Les M, Zetterberg Henrik, Trojanowski John Q, Blennow Kaj.

     Exp Neurol. 2009

     [Links: PMID: 19815015 | DOI länk][Source: PubMed®]
107. No Association of VEGF Polymorphims with Alzheimer's Disease.

     Landgren Sara, Palmér Mona Seibt, Skoog Ingemar, Minthon Lennart, Wallin Anders, Andreasen Niels, Zetterberg Madeleine, Blennow Kaj, Zetterberg Henrik.

     Neuromolecular Med. 2009

     [Links: PMID: 19842071 | DOI länk][Source: PubMed®]
108. Cerebrospinal fluid total tau is associated with shorter survival in dementia with Lewy bodies.

     Boström Fredrik, Hansson Oskar, Blennow Kaj, Gerhardsson Lars, Lundh Thomas, Minthon Lennart, Zetterberg Henrik, Londos Elisabet.

     Dement Geriatr Cogn Disord 2009:28(4):314-9.

     [Links: PMID: 19844105 | DOI länk][Source: PubMed®]

     Web of Science® citations 1
109. Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study.

     Jonsson M, Zetterberg H, van Straaten E, Lind K, Syversen S, Edman A, Blennow K, Rosengren L, Pantoni L, Inzitari D, Wallin A.

     Eur J Neurol. 2009

     [Links: PMID: 19845747 | DOI länk][Source: PubMed®]

     Web of Science® citations 7
110. Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity is increased in Alzheimer disease.

     Chalbot Sonia, Zetterberg Henrik, Blennow Kaj, Fladby Tormod, Grundke-Iqbal Inge, Iqbal Khalid.

     Clin Chem. 2009:55(12):2171-9.

     [Links: PMID: 19850632 | DOI länk][Source: PubMed®]

     Web of Science® citations 9
111. Subcortical vascular dementia biomarker pattern in mild cognitive impairment.

     Bjerke Maria, Andreasson Ulf, Rolstad Sindre, Nordlund Arto, Lind Karin, Zetterberg Henrik, Edman Ake, Blennow Kaj, Wallin Anders.

     Dement Geriatr Cogn Disord 2009:28(4):348-56.

     [Links: PMID: 19864909 | DOI länk][Source: PubMed®]

     Web of Science® citations 3
112. Kinesin Light Chain 1 Gene Haplotypes in Three Conformational Diseases.

     von Otter Malin, Landgren Sara, Nilsson Staffan, Lundvall Caroline, Minthon Lennart, Bogdanovic Nenad, Andreasen Niels, Gustafson Deborah R, Skoog Ingmar, Wallin Anders, Håkansson Anna, Nissbrandt Hans, Zetterberg Madeleine, Tasa Gunnar, Blennow Kaj, Zetterberg Henrik.

     Neuromolecular medicine 2009

     [Links: PMID: 19911314 | DOI länk][Source: PubMed®]

     Web of Science® citations 1
113. Gamma-glutamyltransferase in alcohol use disorders: Modification of decision limits in relation to treatment goals?

     Balldin Jan, Berggren Uif, Berglund Kristina, Blennow Kaj, Fahlke Claudia, Zetterberg Henrik.

     Scand J Clin Lab Invest. 2009

     [Links: PMID: 19929269 | DOI länk][Source: PubMed®]

     Web of Science® citations 0
114. Effects of gamma-Secretase Inhibition on the Amyloid beta Isoform Pattern in a Mouse Model of Alzheimer's Disease.

     Portelius Erik, Zhang Bin, Gustavsson Mikael K, Brinkmalm Gunnar, Westman-Brinkmalm Ann, Zetterberg Henrik, Lee Virginia M-Y, Trojanowski John Q, Blennow Kaj.

     Neuro-degenerative diseases 2009:6(5-6):258-262.

     [Links: PMID: 19955704 | DOI länk][Source: PubMed®]
115. Amyloid and tau cerebrospinal fluid biomarkers in HIV infection.

     Gisslén Magnus, Krut Jan, Andreasson Ulf, Blennow Kaj, Cinque Paola, Brew Bruce J, Spudich Serena, Hagberg Lars, Rosengren Lars, Price Richard W, Zetterberg Henrik.

     BMC Neurol 2009:9:63.

     [Links: PMID: 20028512 | DOI länk][Source: PubMed®]

     Web of Science® citations 11
116. Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease.

     Wesnes K, Edgar C, Andreasen N, Annas P, Basun H, Lannfelt L, Zetterberg H, Blennow K, Minthon L.

     Acta neurologica Scandinavica 2009

     [Links: PMID: 20047570 | DOI länk][Source: PubMed®]

     Web of Science® citations 0
117. Alzheimer's disease: No effect of the CDK5 gene on CSF biomarkers, neuropathology or disease risk.

     Sjölander Annica, Andersson Malin E, Zetterberg Henrik, Minthon Lennart, Bogdanovic Nenad, Blennow Kaj.

     Mol Med Report 2009:2(6):989-92.

     [Links: PMID: 21475932 | DOI länk][Source: PubMed®]

     Web of Science® citations 0
118. The lipocalins, retinol-binding protein-4, lipocalin-2 and lipocalin-type prostaglandin D2-synthase, correlate with markers of inflammatory activity, alcohol intake and blood lipids but not with insulin sensitivity in non-diabetic, middle age Swedish men.

     Wallenius Ville, Elias E, Bergstrom Göran, Zetterberg Henrik, Behre Carl-Johan.

     Experimental and Clinical Endocrinology & Diabetes 2010:100

     [Source: User]
119. Dopamine D2 receptor genotype is associated with increased mortality at a 10-year follow-up of alcohol-dependent individuals.

     Berggren Ulf, Fahlke Claudia, Berglund Kristina J, Wadell Kathleen, Zetterberg Henrik, Blennow Kaj, Thelle Dag, Balldin Jan.

     Alcohol Alcohol. 2010:45(1):1-5.

     [Links: PMID: 19654188 | DOI länk][Source: PubMed®]

     Web of Science® citations 1
120. Amyloid beta and APP as biomarkers for Alzheimer's disease.

     Zetterberg Henrik, Blennow Kaj, Hanse Eric.

     Exp Gerontol. 2010:45(1):23-9.

     [Links: PMID: 19698775 | DOI länk][Source: PubMed®]
121. The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease.

     Wiig E H, Annas P, Basun H, Andreasen N, Lannfelt L, Zetterberg H, Blennow K, Minthon L.

     Acta Neurol Scand. 2010:121(3):186-93.

     [Links: PMID: 19785641 | DOI länk][Source: PubMed®]

     Web of Science® citations 2
122. Total and phosphorylated tau protein as biological markers of Alzheimer's disease.

     Hampel Harald, Blennow Kaj, Shaw Leslie M, Hoessler Yvonne C, Zetterberg Henrik, Trojanowski John Q.

     Exp Gerontol. 2010:45(1):30-40.

     [Links: PMID: 19853650 | DOI länk][Source: PubMed®]
123. Converging molecular pathways in human neural development and degeneration.

     Mattsson Niklas, Sävman Karin, Osterlundh Gustaf, Blennow Kaj, Zetterberg Henrik.

     Neurosci Res. 2010:66(3):330-2.

     [Links: PMID: 19961883 | DOI länk][Source: PubMed®]
124. Converging molecular pathways in human neural development and degeneration.

     Mattsson Niklas, Sävman Karin, Osterlundh Gustaf, Blennow Kaj, Zetterberg Henrik.

     Neurosci Res. 2010:66(3):330-2.

     [Links: PMID: 19961883 | DOI länk][Source: PubMed®]
125. Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract.

     von Otter Malin, Landgren Sara, Nilsson Staffan, Zetterberg Madeleine, Celojevic Dragana, Bergström Petra, Minthon Lennart, Bogdanovic Nenad, Andreasen Niels, Gustafson Deborah R, Skoog Ingmar, Wallin Anders, Tasa Gunnar, Blennow Kaj, Nilsson Michael, Hammarsten Ola, Zetterberg Henrik.

     Mechanisms of ageing and development 2010

     [Links: PMID: 20064547 | DOI länk][Source: PubMed®]

     Web of Science® citations 4
126. Is there a CSF biomarker profile related to depression in elderly women?

     Gudmundsson Pia, Skoog Ingmar, Waern Margda, Blennow Kaj, Zetterberg Henrik, Rosengren Lars, Gustafson Deborah.

     Psychiatry research 2010

     [Links: PMID: 20132991 | DOI länk][Source: PubMed®]
127. Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders.

     Glodzik Lidia, de Santi Susan, Tsui Wai Hon, Mosconi Lisa, Zinkowski Raymond, Pirraglia Elizabeth, Wang Hui Yu, Li Yi, Rich Kenneth E, Zetterberg Henrik, Blennow Kaj, Mehta Pankaj, de Leon Mony J.

     Neurobiology of aging 2010

     [Links: PMID: 20133017 | DOI länk][Source: PubMed®]
128. Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.

     Stomrud Erik, Hansson Oskar, Zetterberg Henrik, Blennow Kaj, Minthon Lennart, Londos Elisabet.

     Arch Neurol. 2010:67(2):217-23.

     [Links: PMID: 20142530 | DOI länk][Source: PubMed®]

     Web of Science® citations 19
129. Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease.

     Portelius Erik, Andreasson Ulf, Ringman John M, Buerger Katharina, Daborg Jonny, Buchhave Peder, Hansson Oskar, Harmsen Andreas, Gustavsson Mikael K, Hanse Eric, Galasko Douglas, Hampel Harald, Blennow Kaj, Zetterberg Henrik.

     Mol Neurodegener 2010:5:2.

     [Links: PMID: 20145736 | DOI länk][Source: PubMed®]

     Web of Science® citations 10
130. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

     Blennow Kaj, Hampel Harald, Weiner Michael, Zetterberg Henrik.

     Nature reviews Neurology 2010

     [Links: PMID: 20157306 | DOI länk][Source: PubMed®]

     Web of Science® citations 118
131. PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses.

     Faux Noel G, Ritchie Craig W, Gunn Adam, Rembach Alan, Tsatsanis Andrew, Bedo Justin, Harrison John, Lannfelt Lars, Blennow Kaj, Zetterberg Henrik, Ingelsson Martin, Masters Colin L, Tanzi Rudolph E, Cummings Jeffrey L, Herd Caroline M, Bush Ashley I.

     Journal of Alzheimer's disease : JAD 2010

     [Links: PMID: 20164561 | DOI länk][Source: PubMed®]

     Web of Science® citations 42
132. Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.

     von Otter Malin, Landgren Sara, Nilsson Staffan, Celojevic Dragana, Bergström Petra, Håkansson Anna, Nissbrandt Hans, Drozdzik Marek, Bialecka Monika, Kurzawski Mateusz, Blennow Kaj, Nilsson Michael, Hammarsten Ola, Zetterberg Henrik.

     BMC Med Genet. 2010:11:36.

     [Links: PMID: 20196834 | DOI länk][Source: PubMed®]

     Web of Science® citations 3
133. Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall.

     Mattsson Niklas, Blennow Kaj, Zetterberg Henrik.

     Clinical chemistry and laboratory medicine : CCLM / FESCC 2010

     [Links: PMID: 20201744 | DOI länk][Source: PubMed®]

     Web of Science® citations 24
134. Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses.

     Brunnström Hans, Rawshani Nina, Zetterberg Henrik, Blennow Kaj, Minthon Lennart, Passant Ulla, Englund Elisabet.

     Alzheimers Dement 2010:6(2):104-9.

     [Links: PMID: 20298970 | DOI länk][Source: PubMed®]

     Web of Science® citations 7
135. Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer's disease.

     Zetterberg Madeleine, Sjolander Annica, von Otter Malin, Seibt Palmer Mona, Landgren Sara, Minthon Lennart, Wallin Anders, Andreasen Niels, Blennow Kaj, Zetterberg Henrik.

     Molecular neurodegeneration 2010:5(1):11.

     [Links: PMID: 20302621 | DOI länk][Source: PubMed®]

     Web of Science® citations 2
136. Memory in individuals with mild cognitive impairment in relation to APOE and CSF Abeta42.

     Thorvaldsson Valgeir, Nordlund Arto, Reinvang Ivar, Blennow Kaj, Zetterberg Henrik, Wallin Anders, Johansson Boo.

     International psychogeriatrics / IPA 2010:1-9.

     [Links: PMID: 20338079 | DOI länk][Source: PubMed®]
137. A novel Abeta isoform pattern in CSF reflects gamma-secretase inhibition in Alzheimer's disease.

     Portelius Erik, Dean Robert A, Gustavsson Mikael K, Andreasson Ulf, Zetterberg Henrik, Siemers Eric, Blennow Kaj.

     Alzheimer's research & therapy 2010:2(2):7.

     [Links: PMID: 20350302 | DOI länk][Source: PubMed®]
138. Combination of Hippocampal Volume and Cerebrospinal Fluid Biomarkers Improves Predictive Value in Mild Cognitive Impairment.

     Eckerström C, Andreasson U, Olsson E, Rolstad S, Blennow K, Zetterberg H, Malmgren H, Edman A, Wallin A.

     Dementia and geriatric cognitive disorders 2010:29(4):294-300.

     [Links: PMID: 20389071 | DOI länk][Source: PubMed®]

     Web of Science® citations 2
139. Combination of hippocampal volume and cerebrospinal fluid biomarkers improves predictive value in mild cognitive impairment.

     Eckerström C, Andreasson U, Olsson E, Rolstad S, Blennow K, Zetterberg H, Malmgren H, Edman A, Wallin A.

     Dement Geriatr Cogn Disord 2010:29(4):294-300.

     [Links: PMID: 20389071 | DOI länk][Source: PubMed®]

     Web of Science® citations 2
140. Proteomics Profiling of Single Organs from Individual Adult Zebrafish.

     Abramsson Alexandra, Westman-Brinkmalm Ann, Pannee Josef, Gustavsson Mikael, von Otter Malin, Blennow Kaj, Brinkmalm Gunnar, Kettunen Petronella, Zetterberg Henrik.

     Zebrafish 2010

     [Links: PMID: 20392139 | DOI länk][Source: PubMed®]

     Web of Science® citations 5
141. Converging Pathways of Chromogranin and Amyloid Metabolism in the Brain.

     Mattsson Niklas, Johansson Per, Hansson Oskar, Wallin Anders, Johansson Jan-Ove, Andreasson Ulf, Andersen Oluf, Haghighi Sara, Olsson Maria, Stridsberg Mats, Svensson Johan, Blennow Kaj, Zetterberg Henrik.

     Journal of Alzheimer's disease : JAD 2010

     [Links: PMID: 20413871 | DOI länk][Source: PubMed®]

     Web of Science® citations 4
142. High Education May Offer Protection Against Tauopathy in Patients with Mild Cognitive Impairment.

     Rolstad Sindre, Nordlund Arto, Eckerström Carl, Gustavsson Marie H, Blennow Kaj, Olesen Pernille J, Zetterberg Henrik, Wallin Anders.

     Journal of Alzheimer's disease : JAD 2010

     [Links: PMID: 20413900 | DOI länk][Source: PubMed®]

     Web of Science® citations 3
143. Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease.

     Portelius Erik, Bogdanovic Nenad, Gustavsson Mikael K, Volkmann Inga, Brinkmalm Gunnar, Zetterberg Henrik, Winblad Bengt, Blennow Kaj.

     Acta neuropathologica 2010

     [Links: PMID: 20419305 | DOI länk][Source: PubMed®]
144. CSF biomarkers predict a more malignant outcome in Alzheimer disease.

     Wallin A K, Blennow K, Zetterberg H, Londos E, Minthon L, Hansson O.

     Neurology 2010:74(19):1531-7.

     [Links: PMID: 20458070 | DOI länk][Source: PubMed®]

     Web of Science® citations 20
145. Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: a biomarker of blood-cerebrospinal fluid barrier permeability.

     Chalbot Sonia, Zetterberg Henrik, Blennow Kaj, Fladby Tormod, Grundke-Iqbal Inge, Iqbal Khalid.

     Neurosci Lett. 2010:478(3):179-83.

     [Links: PMID: 20470866 | DOI länk][Source: PubMed®]

     Web of Science® citations 2
146. Low Incidence of Post-Lumbar Puncture Headache in 1,089 Consecutive Memory Clinic Patients.

     Zetterberg Henrik, Tullhög Kristian, Hansson Oskar, Minthon Lennart, Londos Elisabet, Blennow Kaj.

     European neurology 2010:63(6):326-330.

     [Links: PMID: 20516693 | DOI länk][Source: PubMed®]

     Web of Science® citations 8
147. CSF amyloid-{beta} and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study.

     Alves Guido, Brønnick Kolbjørn, Aarsland Dag, Blennow Kaj, Zetterberg Henrik, Ballard Clive, Kurz Martin Wilhelm, Andreasson Ulf, Tysnes Ole-Bjørn, Larsen Jan Petter, Mulugeta Ezra.

     Journal of neurology, neurosurgery, and psychiatry 2010

     [Links: PMID: 20547614 | DOI länk][Source: PubMed®]

     Web of Science® citations 20
148. Association of the RAGE G82S polymorphism with Alzheimer's disease.

     Daborg Jonny, von Otter Malin, Sjölander Annica, Nilsson Staffan, Minthon Lennart, Gustafson Deborah R, Skoog Ingmar, Blennow Kaj, Zetterberg Henrik.

     J Neural Transm 2010:117(7):861-7.

     [Links: PMID: 20567859 | DOI länk][Source: PubMed®]
149. Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism.

     Mattsson Niklas, Bremell Daniel, Anckarsater Rolf, Blennow Kaj, Anckarsater Henrik, Zetterberg Henrik, Hagberg Lars.

     BMC neurology 2010:10(1):51.

     [Links: PMID: 20569437 | DOI länk][Source: PubMed®]

     Web of Science® citations 5
150. Genetic Variation of the Ghrelin Signaling System in Females With Severe Alcohol Dependence.

     Landgren Sara, Jerlhag Elisabet, Hallman Jarmila, Oreland Lars, Lissner Lauren, Strandhagen Elisabeth, Thelle Dag S, Zetterberg Henrik, Blennow Kaj, Engel Jörgen A.

     Alcoholism, clinical and experimental research 2010

     [Links: PMID: 20586762 | DOI länk][Source: PubMed®]
151. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives.

     Hampel Harald, Frank Richard, Broich Karl, Teipel Stefan J, Katz Russell G, Hardy John, Herholz Karl, Bokde Arun L W, Jessen Frank, Hoessler Yvonne C, Sanhai Wendy R, Zetterberg Henrik, Woodcock Janet, Blennow Kaj.

     Nat Rev Drug Discov 2010:9(7):560-74.

     [Links: PMID: 20592748 | DOI länk][Source: PubMed®]

     Web of Science® citations 89
152. Exposure to wireless phone emissions and serum beta-trace protein.

     Hardell Lennart, Söderqvist Fredrik, Carlberg Michael, Zetterberg Henrik, Mild Kjell Hansson.

     Int J Mol Med. 2010:26(2):301-6.

     [Links: PMID: 20596612][Source: PubMed®]

     Web of Science® citations 1
153. Exposure to wireless phone emissions and serum beta-trace protein.

     Hardell Lennart, Söderqvist Fredrik, Carlberg Michael, Zetterberg Henrik, Mild Kjell Hansson.

     Int J Mol Med. 2010:26(2):301-6.

     [Links: PMID: 20596612][Source: PubMed®]

     Web of Science® citations 1
154. Neurochemical measures co-vary with personality traits: Forensic psychiatric findings replicated in a general population sample.

     Nilsson Thomas, Bromander Sara, Anckarsäter Rolf, Kristiansson Marianne, Forsman Anders, Blennow Kaj, Zetterberg Henrik, Anckarsäter Henrik, Wass Caroline.

     Psychiatry research 2010:178(3):525-530.

     [Links: PMID: 20619466 | DOI länk][Source: PubMed®]

     Web of Science® citations 1
155. Proteomic profiling of cerebrospinal fluid in parkinsonian disorders.

     Constantinescu Radu, Andreasson Ulf, Li Susann, Podust Vladimir N, Mattsson Niklas, Anckarsäter Rolf, Anckarsäter Henrik, Rosengren Lars, Holmberg Björn, Blennow Kaj, Wikkelsö Carsten, Rüetschi Ulla, Zetterberg Henrik.

     Parkinsonism & related disorders 2010

     [Links: PMID: 20620095 | DOI länk][Source: PubMed®]
156. Acute Effect on the Abeta Isoform Pattern in CSF in Response to gamma-Secretase Modulator and Inhibitor Treatment in Dogs.

     Portelius Erik, Van Broeck Bianca, Andreasson Ulf, Gustavsson Mikael K, Mercken Marc, Zetterberg Henrik, Borghys Herman, Blennow Kaj.

     Journal of Alzheimer's disease : JAD 2010

     [Links: PMID: 20634579 | DOI länk][Source: PubMed®]

     Web of Science® citations 12
157. Acute Effect on the Abeta Isoform Pattern in CSF in Response to gamma-Secretase Modulator and Inhibitor Treatment in Dogs.

     Portelius Erik, Van Broeck Bianca, Andreasson Ulf, Gustavsson Mikael K, Mercken Marc, Zetterberg Henrik, Borghys Herman, Blennow Kaj.

     Journal of Alzheimer's disease : JAD 2010

     [Links: PMID: 20634579 | DOI länk][Source: PubMed®]

     Web of Science® citations 12
158. No neurochemical evidence of brain injury after blast overpressure by repeated explosions or firing heavy weapons.

     Blennow K, Jonsson M, Andreasen N, Rosengren L, Wallin A, Hellström P A, Zetterberg H.

     Acta neurologica Scandinavica 2010

     [Links: PMID: 20637009 | DOI länk][Source: PubMed®]

     Web of Science® citations 2
159. No neurochemical evidence of brain injury after blast overpressure by repeated explosions or firing heavy weapons.

     Blennow K, Jonsson M, Andreasen N, Rosengren L, Wallin A, Hellström P A, Zetterberg H.

     Acta neurologica Scandinavica 2010

     [Links: PMID: 20637009 | DOI länk][Source: PubMed®]

     Web of Science® citations 2
160. Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid.

     Selnes Per, Blennow Kaj, Zetterberg Henrik, Grambaite Ramune, Rosengren Lars, Johnsen Lisbeth, Stenset Vidar, Fladby Tormod.

     Cerebrospinal Fluid Res 2010:7:10.

     [Links: PMID: 20673341 | DOI länk][Source: PubMed®]
161. Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid.

     Selnes Per, Blennow Kaj, Zetterberg Henrik, Grambaite Ramune, Rosengren Lars, Johnsen Lisbeth, Stenset Vidar, Fladby Tormod.

     Cerebrospinal Fluid Res 2010:7:10.

     [Links: PMID: 20673341 | DOI länk][Source: PubMed®]
162. Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years.

     Hertze Joakim, Minthon Lennart, Zetterberg Henrik, Vanmechelen Eugeen, Blennow Kaj, Hansson Oskar.

     Journal of Alzheimer's disease : JAD 2010

     [Links: PMID: 20693640 | DOI länk][Source: PubMed®]

     Web of Science® citations 4
163. Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years.

     Hertze Joakim, Minthon Lennart, Zetterberg Henrik, Vanmechelen Eugeen, Blennow Kaj, Hansson Oskar.

     Journal of Alzheimer's disease : JAD 2010

     [Links: PMID: 20693640 | DOI länk][Source: PubMed®]

     Web of Science® citations 4
164. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people.

     De Meyer Geert, Shapiro Fred, Vanderstichele Hugo, Vanmechelen Eugeen, Engelborghs Sebastiaan, De Deyn Peter Paul, Coart Els, Hansson Oskar, Minthon Lennart, Zetterberg Henrik, Blennow Kaj, Shaw Leslie, Trojanowski John Q;
     Alzheimer's Disease Neuroimaging Initiative.

     Arch Neurol. 2010:67(8):949-56.

     [Links: PMID: 20697045 | DOI länk][Source: PubMed®]

     Web of Science® citations 68
165. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people.

     De Meyer Geert, Shapiro Fred, Vanderstichele Hugo, Vanmechelen Eugeen, Engelborghs Sebastiaan, De Deyn Peter Paul, Coart Els, Hansson Oskar, Minthon Lennart, Zetterberg Henrik, Blennow Kaj, Shaw Leslie, Trojanowski John Q;
     Alzheimer's Disease Neuroimaging Initiative.

     Arch Neurol. 2010:67(8):949-56.

     [Links: PMID: 20697045 | DOI länk][Source: PubMed®]

     Web of Science® citations 68
166. Cerebrospinal fluid insulin during non-neurological surgery.

     Bromander Sara, Anckarsäter Rolf, Ahrén Bo, Kristiansson Marianne, Blennow Kaj, Holmäng Agneta, Zetterberg Henrik, Anckarsäter Henrik, Wass Caroline E.

     Journal of neural transmission (Vienna, Austria : 1996) 2010

     [Links: PMID: 20697751 | DOI länk][Source: PubMed®]
167. Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease.

     Mattsson Niklas, Zetterberg Henrik, Blennow Kaj.

     Int J Alzheimers Dis 2010:2010

     [Links: PMID: 20721354 | DOI länk][Source: PubMed®]
168. To know or not to know: ethical issues related to early diagnosis of Alzheimer's disease.

     Mattsson Niklas, Brax David, Zetterberg Henrik.

     Int J Alzheimers Dis 2010:2010

     [Links: PMID: 20798843 | DOI länk][Source: PubMed®]
169. Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid.

     Bjerke Maria, Portelius Erik, Minthon Lennart, Wallin Anders, Anckarsäter Henrik, Anckarsäter Rolf, Andreasen Niels, Zetterberg Henrik, Andreasson Ulf, Blennow Kaj.

     Int J Alzheimers Dis 2010:2010

     [Links: PMID: 20798852 | DOI länk][Source: PubMed®]
170. BACE1 gene variants do not influence BACE1 activity, levels of APP or A.

     Sjölander Annica, Zetterberg Henrik, Andreasson Ulf, Minthon Lennart, Blennow Kaj.

     Mol Neurodegener 2010:5:37.

     [Links: PMID: 20849576 | DOI länk][Source: PubMed®]

     Web of Science® citations 2
171. BACE1 gene variants do not influence BACE1 activity, levels of APP or A.

     Sjölander Annica, Zetterberg Henrik, Andreasson Ulf, Minthon Lennart, Blennow Kaj.

     Mol Neurodegener 2010:5:37.

     [Links: PMID: 20849576 | DOI länk][Source: PubMed®]

     Web of Science® citations 2
172. Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease.

     Thorsell Annika, Bjerke Maria, Gobom Johan, Brunhage Eva, Vanmechelen Eugeen, Andreasen Niels, Hansson Oskar, Minthon Lennart, Zetterberg Henrik, Blennow Kaj.

     Brain research 2010

     [Links: PMID: 20875798 | DOI länk][Source: PubMed®]

     Web of Science® citations 1
173. Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease.

     Thorsell Annika, Bjerke Maria, Gobom Johan, Brunhage Eva, Vanmechelen Eugeen, Andreasen Niels, Hansson Oskar, Minthon Lennart, Zetterberg Henrik, Blennow Kaj.

     Brain Res. 2010:1362:13-22.

     [Links: PMID: 20875798 | DOI länk][Source: PubMed®]

     Web of Science® citations 1
174. cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases.

     Spitzer Philipp, Klafki Hans Wolfgang, Blennow Kaj, Buée Luc, Esselmann Hermann, Herruka Sanna-Kaisa, Jimenez Connie, Klivenyi Peter, Lewczuk Piotr, Maler Juan Manuel, Markus Katrin, Meyer Helmut E, Morris Chris, Müller Thorsten, Otto Markus, Parnetti Lucilla, Soininen Hilkka, Schraen Susanna, Teunissen Charlotte, Vecsei Laszlo, Zetterberg Henrik, Wiltfang Jens.

     Int J Alzheimers Dis 2010:2010

     [Links: PMID: 20886057 | DOI länk][Source: PubMed®]
175. CSF Levels of Heart Fatty Acid Binding Protein are Altered During Early Phases of Alzheimer's Disease.

     Chiasserini Davide, Parnetti Lucilla, Andreasson Ulf, Zetterberg Henrik, Giannandrea David, Calabresi Paolo, Blennow Kaj.

     Journal of Alzheimer's disease : JAD 2010

     [Links: PMID: 20930282 | DOI länk][Source: PubMed®]

     Web of Science® citations 4
176. Use of theragnostic markers to select drugs for phase II/III trials for Alzheimer disease.

     Zetterberg Henrik, Mattsson Niklas, Blennow Kaj, Olsson Bob.

     Alzheimers Res Ther 2010:2(6):32.

     [Links: PMID: 21122172 | DOI länk][Source: PubMed®]
177. Neuroinflammation Screening in Immunotherapy Trials against Alzheimer's Disease.

     Andreasen Niels, Blennow Kaj, Zetterberg Henrik.

     Int J Alzheimers Dis 2010:2010:638379.

     [Links: PMID: 21197432 | DOI länk][Source: PubMed]
178. A.

     Gao Carol Man, Yam Alice Y, Wang Xuemei, Magdangal Erika, Salisbury Cleo, Peretz David, Zuckermann Ronald N, Connolly Michael D, Hansson Oskar, Minthon Lennart, Zetterberg Henrik, Blennow Kaj, Fedynyshyn Joseph P, Allauzen Sophie.

     PLoS ONE 2010:5(12):e15725.

     [Links: PMID: 21209907 | DOI länk][Source: PubMed®]
179. Cerebrospinal fluid analysis should be considered in patients with cognitive problems.

     Zetterberg Henrik, Mattsson Niklas, Blennow Kaj.

     Int J Alzheimers Dis 2010:2010:163065.

     [Links: PMID: 21487447 | DOI länk][Source: PubMed®]
180. Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years.

     Hertze Joakim, Minthon Lennart, Zetterberg Henrik, Vanmechelen Eugeen, Blennow Kaj, Hansson Oskar.

     J Alzheimers Dis. 2010:21(4):1119-28.

     [Links: PMID: 21504133][Source: PubMed®]
181. CSF amyloid .

     Mulugeta Ezra, Londos Elisabet, Ballard Clive, Alves Guido, Zetterberg Henrik, Blennow Kaj, Skogseth Ragnhild, Minthon Lennart, Aarsland Dag.

     J Neurol Neurosurg Psychiatr. 2011:82(2):160-4.

     [Links: PMID: 21047883 | DOI länk][Source: PubMed®]

     Web of Science® citations 1
182. S-100B is superior to NSE, BDNF and GFAP in predicting outcome of resuscitation from cardiac arrest with hypothermia treatment.

     Mörtberg Erik, Zetterberg Henrik, Nordmark Johanna, Blennow Kaj, Rosengren Lars, Rubertsson Sten.

     Resuscitation 2011:82(1):26-31.

     [Links: PMID: 21071131 | DOI länk][Source: PubMed®]
183. Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-.

     Sagare Abhay P, Deane Rashid, Zetterberg Henrik, Wallin Anders, Blennow Kaj, Zlokovic Berislav V.

     J Alzheimers Dis. 2011:24(1):25-34.

     [Links: PMID: 21157031 | DOI länk][Source: PubMed]

     Web of Science® citations 2
184. Ubiquitin Carboxyl-Terminal Esterase L1 (UCHL1) S18Y Polymorphism In Patients With Cataracts.

     Rudolph Thiemo, Sjölander Annica, Palmér Mona Seibt, Minthon Lennart, Wallin Anders, Andreasen Niels, Tasa Gunnar, Juronen Erkki, Blennow Kaj, Zetterberg Henrik, Zetterberg Madeleine.

     Ophthalmic genetics 2011

     [Links: PMID: 21268678 | DOI länk][Source: PubMed®]
185. Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Diagnostic Performance in a Homogeneous Mono-Center Population.

     Johansson Per, Mattsson Niklas, Hansson Oskar, Wallin Anders, Johansson Jan-Ove, Andreasson Ulf, Zetterberg Henrik, Blennow Kaj, Svensson Johan.

     Journal of Alzheimer's disease : JAD 2011

     [Links: PMID: 21297262 | DOI länk][Source: PubMed®]

     Web of Science® citations 2
186. Characterization of the brain .

     Mustafiz Tamanna, Portelius Erik, Gustavsson Mikael K, Hölttä Mikko, Zetterberg Henrik, Blennow Kaj, Nordberg Agneta, Lithner Christina Unger.

     Neurodegener Dis 2011:8(5):352-63.

     [Links: PMID: 21346320 | DOI länk][Source: PubMed]
187. Expression of the gene encoding the ghrelin receptor in rats selected for differential alcohol preference.

     Landgren Sara, Engel Jörgen A, Hyytiä Petri, Zetterberg Henrik, Blennow Kaj, Jerlhag Elisabet.

     Behav Brain Res. 2011:221(1):182-8.

     [Links: PMID: 21392542 | DOI länk][Source: PubMed]
188. Central nervous system lipocalin-type prostaglandin D2-synthase (L-PGDS) is correlated with orexigenic neuropeptides, visceral adiposity and markers of the hypothalamic-pituitary-adrenal axis in obese humans.

     Elias Erik, Benrick Anna, Behre Carl Johan, Ekman Rolf, Zetterberg Henrik, Stenlöf Kaj, Wallenius Ville.

     Journal of neuroendocrinology 2011

     [Links: PMID: 21438929 | DOI länk][Source: PubMed®]

     Web of Science® citations 0
189. Discriminatory Analysis of Biochip-Derived Protein Patterns in CSF and Plasma in Neurodegenerative Diseases.

     Rosén Christoffer, Mattsson Niklas, Johansson Per M, Andreasson Ulf, Wallin Anders, Hansson Oskar, Johansson Jan-Ove, Lamont John, Svensson Johan, Blennow Kaj, Zetterberg Henrik.

     Front Aging Neurosci 2011:3:1.

     [Links: PMID: 21442044 | DOI länk][Source: PubMed®]
190. TOMM40 poly-T variants and cerebrospinal fluid amyloid beta levels in the elderly.

     Pomara Nunzio, Bruno Davide, Nierenberg Jay J, Sidtis John J, Martiniuk Frank T, Mehta Pankaj D, Zetterberg Henrik, Blennow Kaj.

     Neurochem Res. 2011:36(6):1124-8.

     [Links: PMID: 21455713 | DOI länk][Source: PubMed]
191. Antihypertensive Therapy Is Associated with Reduced Rate of Conversion to Alzheimer's Disease in Midregional Proatrial Natriuretic Peptide Stratified Subjects with Mild Cognitive Impairment.

     Schneider Philine, Buerger Katharina, Teipel Stefan, Uspenskaya Olga, Hartmann Oliver, Hansson Oskar, Minthon Lennart, Rujescu Dan, Moeller Hans-Juergen, Zetterberg Henrik, Blennow Kaj, Ernst Andrea, Bergmann Andreas, Hampel Harald.

     Biological psychiatry 2011

     [Links: PMID: 21457948 | DOI länk][Source: PubMed®]

     Web of Science® citations 2
192. Blood-cerebrospinal fluid barrier permeability in Alzheimer's disease.

     Chalbot Sonia, Zetterberg Henrik, Blennow Kaj, Fladby Tormod, Andreasen Niels, Grundke-Iqbal Inge, Iqbal Khalid.

     J Alzheimers Dis. 2011:25(3):505-15.

     [Links: PMID: 21471645 | DOI länk][Source: PubMed]

     Web of Science® citations 0
193. Research highlights.

     Mattsson Niklas, Olsson Bob, Andreasson Ulf, Portelius Erik, Zetterberg Henrik.

     Biomark Med 2011:5(2):201-3.

     [Links: PMID: 21473724 | DOI länk][Source: PubMed®]
194. Mild dementia is associated with increased adrenal secretion of cortisol and precursor sex steroids in women.

     Johansson Per, Johansson Jan-Ove, Labrie Fernand, Mattsson Niklas, Hansson Oskar, Blennow Kaj, Zetterberg Henrik, Wallin Anders, Ohlsson Claes, Svensson Johan.

     Clinical endocrinology 2011

     [Links: PMID: 21521348 | DOI länk][Source: PubMed®]

     Web of Science® citations 0
195. No Association of LOXL1 Gene Polymorphisms with Alzheimer's Disease.

     Abramsson Alexandra, Landgren Sara, Zetterberg Madeleine, Seibt Palmer Mona, Minthon Lennart, Gustafson Deborah R, Skoog Ingmar, Blennow Kaj, Zetterberg Henrik.

     Neuromolecular medicine 2011

     [Links: PMID: 21559813 | DOI länk][Source: PubMed®]
196. Cerebrospinal fluid microglial markers in Alzheimer's disease: elevated chitotriosidase activity but lack of diagnostic utility.

     Mattsson Niklas, Tabatabaei Shahrzad, Johansson Per, Hansson Oskar, Andreasson Ulf, Månsson Jan-Eric, Johansson Jan-Ove, Olsson Bob, Wallin Anders, Svensson Johan, Blennow Kaj, Zetterberg Henrik.

     Neuromolecular Med. 2011:13(2):151-9.

     [Links: PMID: 21567187 | DOI länk][Source: PubMed®]
197. Cerebrospinal fluid microglial markers in Alzheimer's disease: elevated chitotriosidase activity but lack of diagnostic utility.

     Mattsson Niklas, Tabatabaei Shahrzad, Johansson Per, Hansson Oskar, Andreasson Ulf, Månsson Jan-Eric, Johansson Jan-Ove, Olsson Bob, Wallin Anders, Svensson Johan, Blennow Kaj, Zetterberg Henrik.

     Neuromolecular Med. 2011:13(2):151-9.

     [Links: PMID: 21567187 | DOI länk][Source: PubMed®]
198. Amyloid-.

     Rolstad Sindre, Berg Anne Ingeborg, Bjerke Maria, Blennow Kaj, Johansson Boo, Zetterberg Henrik, Wallin Anders.

     J Alzheimers Dis. 2011:26(1):135-42.

     [Links: PMID: 21593572 | DOI länk][Source: PubMed]
199. Reward-related genes and personality traits in alcohol-dependent individuals: a pilot case control study.

     Landgren Sara, Berglund Kristina, Jerlhag Elisabet, Fahlke Claudia, Balldin Jan, Berggren Ulf, Zetterberg Henrik, Blennow Kaj, Engel Jörgen A.

     Neuropsychobiology 2011:64(1):38-46.

     [Links: PMID: 21606657 | DOI länk][Source: PubMed®]

     Web of Science® citations 0
200. A new member in the biomarker discovery toolbox.

     Mattsson Niklas, Olsson Bob, Andreasson Ulf, Portelius Erik, Zetterberg Henrik.

     Biomark Med 2011:5(2):202.

     [Links: PMID: 21612119][Source: PubMed®]
201. Troponin T: more than acute myocardial infarction.

     Mattsson Niklas, Olsson Bob, Andreasson Ulf, Portelius Erik, Zetterberg Henrik.

     Biomark Med 2011:5(2):203.

     [Links: PMID: 21612120][Source: PubMed®]
202. Do Alcohol-dependent Individuals with DRD2 A1 Allele Have an Increased Risk of Relapse? A Pilot Study

     Dahlgren Angelica, Wargelius Hanna-Linn, Berglund Kristina J, Fahlke Claudia, Blennow Kaj, Zetterberg Henrik, Oreland Lars, Berggren Ulf, Balldin Jan.

     Alcohol and alcoholism (Oxford, Oxfordshire) 2011

     [Links: PMID: 21613303 | DOI länk][Source: PubMed®]

     Web of Science® citations 1
203. Growth factors in Parkinson's disease.

     Mattsson Niklas, Olsson Bob, Andreasson Ulf, Portelius Erik, Zetterberg Henrik.

     Biomark Med 2011:5(2):201-2.

     [Links: PMID: 21614801][Source: PubMed®]
204. It is all about clearance.

     Mattsson Niklas, Olsson Bob, Andreasson Ulf, Portelius Erik, Zetterberg Henrik.

     Biomark Med 2011:5(2):202.

     [Links: PMID: 21614802][Source: PubMed®]
205. Identification of Novel .

     Ohrfelt Annika, Zetterberg Henrik, Andersson Kerstin, Persson Rita, Secic Dzemila, Brinkmalm Gunnar, Wallin Anders, Mulugeta Ezra, Francis Paul T, Vanmechelen Eugeen, Aarsland Dag, Ballard Clive, Blennow Kaj, Westman-Brinkmalm Ann.

     Neurochemical research 2011

     [Links: PMID: 21674238 | DOI länk][Source: PubMed®]

     Web of Science® citations 0
206. Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid {beta}-peptides in human cerebrospinal fluid.

     Halim Adnan, Brinkmalm Gunnar, Rüetschi Ulla, Westman-Brinkmalm Ann, Portelius Erik, Zetterberg Henrik, Blennow Kaj, Larson Göran, Nilsson Jonas.

     Proc Natl Acad Sci U.S.A. 2011:108(29):11848-53.

     [Links: PMID: 21712440 | DOI länk][Source: PubMed®]

     Web of Science® citations 3
207. Novel A.

     Portelius Erik, Mattsson Niklas, Andreasson Ulf, Blennow Kaj, Zetterberg Henrik.

     Current pharmaceutical design 2011

     [Links: PMID: 21728980][Source: PubMed®]
208. The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers.

     Mattsson Niklas, Andreasson Ulf, Persson Staffan, Arai Hiroyuki, Batish Sat Dev, Bernardini Sergio, Bocchio-Chiavetto Luisella, Blankenstein Marinus A, Carrillo Maria C, Chalbot Sonia, Coart Els, Chiasserini Davide, Cutler Neal, Dahlfors Gunilla, Duller Stefan, Fagan Anne M, Forlenza Orestes, Frisoni Giovanni B, Galasko Douglas, Galimberti Daniela, Hampel Harald, Handberg Aase, Heneka Michael T, Herskovits Adrianna Z, Herukka Sanna-Kaisa, Holtzman David M, Humpel Christian, Hyman Bradley T, Iqbal Khalid, Jucker Mathias et al [ Zetterberg H Nr. 77 ] [ Blennow K Nr. 78 ].

     Alzheimers Dement 2011:7(4):386-395.e6.

     [Links: PMID: 21784349 | DOI länk][Source: PubMed®]

     Web of Science® citations 6
209. Neuroendocrine Assessment of Serotonergic, Dopaminergic, and Noradrenergic Functions in Alcohol-Dependent Individuals.

     Fahlke Claudia, Berggren Ulf, Berglund Kristina J, Zetterberg Henrik, Blennow Kaj, Engel Jörgen A, Balldin Jan.

     Alcoholism, clinical and experimental research 2011

     [Links: PMID: 21797890 | DOI länk][Source: PubMed®]
210. The N-terminal domain of .

     Hesse Camilla, Johansson Inger, Mattsson Niklas, Bremell Daniel, Andreasson Ulf, Halim Adnan, Anckarsäter Rolf, Blennow Kaj, Anckarsäter Henrik, Zetterberg Henrik, Larson Göran, Hagberg Lars, Grahn Ammi.

     Biochem Biophys Res Commun. 2011:412(3):494-9.

     [Links: PMID: 21843510 | DOI länk][Source: PubMed®]

     Web of Science® citations 1
211. The N-terminal domain of .

     Hesse Camilla, Johansson Inger, Mattsson Niklas, Bremell Daniel, Andreasson Ulf, Halim Adnan, Anckarsäter Rolf, Blennow Kaj, Anckarsäter Henrik, Zetterberg Henrik, Larson Göran, Hagberg Lars, Grahn Ammi.

     Biochem Biophys Res Commun. 2011:412(3):494-9.

     [Links: PMID: 21843510 | DOI länk][Source: PubMed®]

     Web of Science® citations 1
212. The N-terminal domain of .

     Hesse Camilla, Johansson Inger, Mattsson Niklas, Bremell Daniel, Andreasson Ulf, Halim Adnan, Anckarsäter Rolf, Blennow Kaj, Anckarsäter Henrik, Zetterberg Henrik, Larson Göran, Hagberg Lars, Grahn Ammi.

     Biochem Biophys Res Commun. 2011:412(3):494-9.

     [Links: PMID: 21843510 | DOI länk][Source: PubMed®]

     Web of Science® citations 1
213. Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease.

     Bjerke Maria, Zetterberg Henrik, Edman Åke, Blennow Kaj, Wallin Anders, Andreasson Ulf.

     J Alzheimers Dis. 2011:27(3):665-76.

     [Links: PMID: 21860087 | DOI länk][Source: PubMed]

     Web of Science® citations 0
214. Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes.

     Bech Sara, Hjermind Lena E, Salvesen Lisette, Nielsen Jørgen E, Heegaard Niels H H, Jørgensen Henrik L, Rosengren Lars, Blennow Kaj, Zetterberg Henrik, Winge Kristian.

     Parkinsonism & related disorders 2011

     [Links: PMID: 21873100 | DOI länk][Source: PubMed®]
215. SILAC zebrafish for quantitative analysis of protein turnover and tissue regeneration.

     Westman-Brinkmalm Ann, Abramsson Alexandra, Pannee Josef, Gang Chen, Gustavsson Mikael K, von Otter Malin, Blennow Kaj, Brinkmalm Gunnar, Heumann Hermann, Zetterberg Henrik.

     J Proteomics 2011:75(2):425-34.

     [Links: PMID: 21890006 | DOI länk][Source: PubMed]

     Web of Science® citations 0
216. Cerebrospinal Fluid Levels of sAPP.

     Mulugeta Ezra, Londos Elisabet, Hansson Oskar, Ballard Clive, Skogseth Ragnhild, Minthon Lennart, Blennow Kaj, Zetterberg Henrik, Aarsland Dag.

     Int J Alzheimers Dis 2011:2011:495025.

     [Links: PMID: 21966597 | DOI länk][Source: PubMed]
217. [Automated cerebrospinal fluid cell count. A valuable contribution to diagnostics of brain diseases].

     Wall Mariann, Mattsson Niklas, Zetterberg Henrik, Blennow Kaj.

     Lakartidningen 2011:108(40):1972-3.

     [Links: PMID: 22111239][Source: PubMed]
218. Biomarkers for microglial activation in Alzheimer's disease.

     Lautner Ronald, Mattsson Niklas, Schöll Michael, Augutis Kristin, Blennow Kaj, Olsson Bob, Zetterberg Henrik.

     Int J Alzheimers Dis 2011:2011:939426.

     [Links: PMID: 22114747 | DOI länk][Source: PubMed]
219. Screening for new biomarkers for subcortical vascular dementia and Alzheimer's disease.

     Ohrfelt Annika, Andreasson Ulf, Simon Adam, Zetterberg Henrik, Edman Ake, Potter William, Holder Daniel, Devanarayan Viswanath, Seeburger Jeffrey, Smith A David, Blennow Kaj, Wallin Anders.

     Dement Geriatr Cogn Dis Extra 2011:1(1):31-42.

     [Links: PMID: 22163231 | DOI länk][Source: PubMed]
220. Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid .

     Zetterberg Henrik, Mörtberg Erik, Song Linan, Chang Lei, Provuncher Gail K, Patel Purvish P, Ferrell Evan, Fournier David R, Kan Cheuk W, Campbell Todd G, Meyer Ray, Rivnak Andrew J, Pink Brian A, Minnehan Kaitlin A, Piech Tomasz, Rissin David M, Duffy David C, Rubertsson Sten, Wilson David H, Blennow Kaj.

     PLoS ONE 2011:6(12):e28263.

     [Links: PMID: 22194817 | DOI länk][Source: PubMed]
221. Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly.

     Glodzik Lidia, Mosconi Lisa, Tsui Wai, de Santi Susan, Zinkowski Raymond, Pirraglia Elizabeth, Rich Kenneth E, McHugh Pauline, Li Yi, Williams Schantel, Ali Fahad, Zetterberg Henrik, Blennow Kaj, Mehta Pankaj, de Leon Mony J.

     Neurobiol Aging 2012:33(7):1215-27.

     [Links: PMID: 21530003 | DOI länk][Source: PubMed]
222. Evaluation of plasma A.

     Hansson Oskar, Stomrud Erik, Vanmechelen Eugeen, Östling Svante, Gustafson Deborah R, Zetterberg Henrik, Blennow Kaj, Skoog Ingmar.

     J Alzheimers Dis. 2012:28(1):231-8.

     [Links: PMID: 21955816 | DOI länk][Source: PubMed]

     Web of Science® citations 0
223. Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants.

     Bruno Davide, Pomara Nunzio, Nierenberg Jay, Ritchie James C, Lutz Michael W, Zetterberg Henrik, Blennow Kaj.

     Exp Gerontol. 2012:47(5):347-52.

     [Links: PMID: 21983493 | DOI länk][Source: PubMed]

     Web of Science® citations 0
224. Measurement of A.

     Slemmon J Randall, Meredith Jere, Guss Valerie, Andreasson Ulf, Andreasen Niels, Zetterberg Henrik, Blennow Kaj.

     J Neurochem. 2012:120(2):325-33.

     [Links: PMID: 22023354 | DOI länk][Source: PubMed]

     Web of Science® citations 0
225. Interaction of apolipoprotein E genotype with smoking and physical inactivity on coronary heart disease risk in men and women.

     Gustavsson Jaana, Mehlig Kirsten, Leander Karin, Strandhagen Elisabeth, Björck Lena, Thelle Dag S, Lissner Lauren, Blennow Kaj, Zetterberg Henrik, Nyberg Fredrik.

     Atherosclerosis 2012:220(2):486-92.

     [Links: PMID: 22071360 | DOI länk][Source: PubMed]

     Web of Science® citations 0
226. Leukocyte Telomere Length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's Disease: A pilot study.

     Movérare-Skrtic Sofia, Johansson Per, Mattsson Niklas, Hansson Oskar, Wallin Anders, Johansson Jan-Ove, Zetterberg Henrik, Blennow Kaj, Svensson Johan.

     Exp Gerontol. 2012:47(2):179-82.

     [Links: PMID: 22210159 | DOI länk][Source: PubMed]
227. Cerebrospinal fluid levels of .

     Buchhave Peder, Minthon Lennart, Zetterberg Henrik, Wallin Asa K, Blennow Kaj, Hansson Oskar.

     Arch Gen Psychiatry 2012:69(1):98-106.

     [Links: PMID: 22213792 | DOI länk][Source: PubMed]

     Web of Science® citations 2
228. Pyroglutamate amyloid .

     Wittnam Jessica L, Portelius Erik, Zetterberg Henrik, Gustavsson Mikael K, Schilling Stephan, Koch Birgit, Demuth Hans-Ulrich, Blennow Kaj, Wirths Oliver, Bayer Thomas A.

     J Biol Chem. 2012:287(11):8154-62.

     [Links: PMID: 22267726 | DOI länk][Source: PubMed]

     Web of Science® citations 0
229. Evaluation of the performance of novel a.

     Portelius Erik, Gustavsson Mikael K, Zetterberg Henrik, Andreasson Ulf, Blennow Kaj.

     Neurodegener Dis 2012:10(1-4):138-40.

     [Links: PMID: 22302034 | DOI länk][Source: PubMed]
230. BACE1 inhibition induces a specific cerebrospinal fluid .

     Mattsson Niklas, Rajendran Lawrence, Zetterberg Henrik, Gustavsson Mikael, Andreasson Ulf, Olsson Maria, Brinkmalm Gunnar, Lundkvist Johan, Jacobson Laura H, Perrot Ludovic, Neumann Ulf, Borghys Herman, Mercken Marc, Dhuyvetter Deborah, Jeppsson Fredrik, Blennow Kaj, Portelius Erik.

     PLoS ONE 2012:7(2):e31084.

     [Links: PMID: 22328928 | DOI länk][Source: PubMed]
231. Cerebrospinal fluid profiles of amyloid .

     Rosén Christoffer, Andreasson Ulf, Mattsson Niklas, Marcusson Jan, Minthon Lennart, Andreasen Niels, Blennow Kaj, Zetterberg Henrik.

     Neuromolecular Med. 2012:14(1):65-73.

     [Links: PMID: 22350541 | DOI länk][Source: PubMed]
232. Multiplexing and multivariate analysis in neurodegeneration.

     Andreasson Ulf, Portelius Erik, Pannee Josef, Zetterberg Henrik, Blennow Kaj.

     Methods (San Diego, Calif.) 2012

     [Links: PMID: 22391487 | DOI länk][Source: PubMed]
233. Power tools for Alzheimer's disease - an electrochemical preamp for A.

     Zetterberg Henrik, Hammarström Per.

     Journal of neurochemistry 2012

     [Links: PMID: 22409410 | DOI länk][Source: PubMed]
234. The cerebrospinal fluid proteome in HIV infection: change associated with disease severity.

     Angel Thomas E, Jacobs Jon M, Spudich Serena S, Gritsenko Marina A, Fuchs Dietmar, Liegler Teri, Zetterberg Henrik, Camp David G, Price Richard W, Smith Richard D.

     Clin Proteomics 2012:9(1):3.

     [Links: PMID: 22433316 | DOI länk][Source: PubMed]
235. Lower CSF Amyloid Beta Peptides and Higher F2-Isoprostanes in Cognitively Intact Elderly Individuals With Major Depressive Disorder.

     Pomara Nunzio, Bruno Davide, Sarreal Antero S, Hernando Raymundo T, Nierenberg Jay, Petkova Eva, Sidtis John J, Wisniewski Thomas M, Mehta Pankaj D, Pratico Domenico, Zetterberg Henrik, Blennow Kaj.

     Am J Psychiatry 2012:169(5):523-30.

     [Links: PMID: 22456821 | DOI länk][Source: PubMed]
236. Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease.

     Blennow Kaj, Zetterberg Henrik, Rinne Juha O, Salloway Stephen, Wei Jenny, Black Ronald, Grundman Michael, Liu Enchi;
     for the AAB-001 201/202 Investigators.

     Archives of neurology 2012

     [Links: PMID: 22473769 | DOI länk][Source: PubMed]
237. Longitudinal Cerebrospinal Fluid Biomarkers over Four Years in Mild Cognitive Impairment.

     Mattsson Niklas, Portelius Erik, Rolstad Sindre, Gustavsson Mikael, Andreasson Ulf, Stridsberg Mats, Wallin Anders, Blennow Kaj, Zetterberg Henrik.

     Journal of Alzheimer's disease : JAD 2012

     [Links: PMID: 22475796 | DOI länk][Source: PubMed]
238. Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer's disease.

     Daborg Jonny, Andreasson Ulf, Pekna Marcela, Lautner Ronald, Hanse Eric, Minthon Lennart, Blennow Kaj, Hansson Oskar, Zetterberg Henrik.

     Journal of neural transmission (Vienna, Austria : 1996) 2012

     [Links: PMID: 22488444 | DOI länk][Source: PubMed]
239. CSF-biomarkers in Olympic boxing: diagnosis and effects of repetitive head trauma.

     Neselius Sanna, Brisby Helena, Theodorsson Annette, Blennow Kaj, Zetterberg Henrik, Marcusson Jan.

     PLoS ONE 2012:7(4):e33606.

     [Links: PMID: 22496755 | DOI länk][Source: PubMed]
240. Amyloid-.

     Portelius Erik, Zetterberg Henrik, Dean Robert A, Marcil Alexandre, Bourgeois Philippe, Nutu Magdalena, Andreasson Ulf, Siemers Eric, Mawuenyega Kwasi G, Sigurdson Wendy C, May Patrick C, Paul Steven M, Holtzman David M, Blennow Kaj, Bateman Randall J.

     Journal of Alzheimer's disease : JAD 2012

     [Links: PMID: 22531418 | DOI länk][Source: PubMed]
241. Monte Carlo feature selection and rule-based models to predict Alzheimer's disease in mild cognitive impairment.

     Kruczyk Marcin, Zetterberg Henrik, Hansson Oskar, Rolstad Sindre, Minthon Lennart, Wallin Anders, Blennow Kaj, Komorowski Jan, Andersson Mats Gunnar.

     Journal of neural transmission (Vienna, Austria : 1996) 2012

     [Links: PMID: 22573144 | DOI länk][Source: PubMed]
242. An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid .

     Brinkmalm Gunnar, Portelius Erik, Ohrfelt Annika, Mattsson Niklas, Persson Rita, Gustavsson Mikael K, Vite Charles H, Gobom Johan, Månsson Jan-Eric, Nilsson Jonas, Halim Adnan, Larson Göran, Rüetschi Ulla, Zetterberg Henrik, Blennow Kaj, Brinkmalm Ann.

     J Mass Spectrom 2012:47(5):591-603.

     [Links: PMID: 22576872 | DOI länk][Source: PubMed]

Book (1)

1. En handbok om tidig diagnostik och behandling.

   Zetterberg Henrik, Blennow Kaj.

   Sollentuna: Pfizer; 2009.

   [Source: User]

Book Chapter (4)

1. Cerebrospinal fluid markers for early and accurate diagnosis of Alzheimer's disease.

   Zetterberg Henrik, Blennow Kaj.

   Neurodégénérescence et vieillissement cerebral. Paris: Solal; 2004,

   [Source: User]
2. RNA interference: applications in research on amyloidogenesis in Alzheimer’s disease.

   Blennow Kaj, Zetterberg Henrik, Xia Weiming.

   Trends in RNA research. New York: Nova Science Publishers; 2006, pp 23-38. ISBN 9781594545061.

   [Links: Books][Source: User]
3. EBNA2 Transcription Regulation in EBV Latency.

   Zetterberg Henrik, Rymo Lars.

   Epstein-Barr virus: Pathogenesis, Molecular Biology and Infectious Control. New York: Horizon Press; 2006,

   [Source: User]
4. Molecular and biological markers for Alzheimer’s disease.

   Blennow Kaj, Zetterberg Henrik.

   Neurobiology of Alzheimer's disease. Oxford: Oxford University Press; 2007, pp 343-57. ISBN 9780198566618.

   [Links: Books][Source: User]

Conference Paper - Peer reviewed (1)

1. Transcranial Doppler microembolic signals and serum S100ß during transcatheter aortic valve implantation.

   Reinsfelt Bjorn, Westerlind Anne, Ioanes Dan, Zetterberg Henrik, Ricksten Sven-Erik.

   Vienna, Austria: The 26th Annual Meeting of the European Association of Cardiothoracic Anaesthesiologists; 2011.

   [Source: User]

Conference Poster (1)

1. Flt3-L is a novel biomarker increased in cerebrospinal fluid of patients with primary fibromyalgia and Sjogren syndrome.

   Bjersing Jan, Dehlin Mats, Zetterberg Henrik, Larsson Anette, Erlandsson Malin, Mannerkorpi Kaisa, Bokarewa Maria.

   Atlanta: American College of Rheumatology 2010 Annual Scientific Meeting; 2010.

   [Source: User]

   Web of Science® citations 3

Article - Other scientific (25)

1. The transcobalamin codon 259 polymorphism should be designated 776C>G, not 775G>C.

   Zetterberg Henrik, Palmér Mona, Boreström Cecilia, Rymo Lars, Blennow Kaj.

   Blood 2003:101(9):3749-50; author repl.

   [Links: PMID: 12707225 | DOI länk][Source: PubMed®]

   Web of Science® citations 5
2. Epstein-Barr virus nukleära antigen 1 och konsten att gömma sig i immunförsvaret.

   Zetterberg Henrik.

   Medikament 2004:9(3)

   [Source: User]
3. Apolipoprotein E polymorphism in patients with cataract.

   Zetterberg M, Zetterberg H, Palmér M, Rymo L, Blennow K, Tasa G, Juronen E, Veromann S, Teesalu P, Karlsson J-O, Höglund K.

   Br J Ophthalmol 2004:88(5):716-8.

   [Links: PMID: 15090431][Source: PubMed®]

   Web of Science® citations 3
4. False-negative result in the detection of an IgM monoclonal protein by capillary zone electrophoresis.

   Zetterberg Henrik, Nilsson-Ehle Herman.

   Clin Chem. 2004:50(10):1878-80.

   [Links: PMID: 15292071 | DOI länk][Source: PubMed®]

   Web of Science® citations 5
5. Elevated total tau/phospho-tau ratio in autopsy-proven Creutzfeldt-Jakob disease with negative 14-3-3 test results.

   Zetterberg H, Blennow K.

   Neurol Sci. 2004:25(5):301-2.

   [Links: PMID: 15624089 | DOI länk][Source: PubMed®]

   Web of Science® citations 4
6. Increased serum concentrations of intestinal alkaline phosphatase in peritoneal dialysis.

   Zetterberg Henrik.

   Clin Chem. 2005:51(3):675-6.

   [Links: PMID: 15738527 | DOI länk][Source: PubMed®]

   Web of Science® citations 1
7. The transcobalamin 776C > G polymorphism may be a modifiable genetic risk factor for Alzheimer's disease.

   Zetterberg Henrik, Nexö Ebba, Minthon Lennart, Boson Roberta, Regland Björn, McCaddon Andrew, Blennow K A.

   International psychogeriatrics / IPA 2005:17(2):329-31.

   [Links: PMID: 16050442][Source: PubMed®]

   Web of Science® citations 2
8. Evolution, exaptation, and stereopsis.

   Zetterberg Henrik, Zetterberg Madeleine.

   Arch Ophthalmol. 2005:123(9):1281; author reply 1.

   [Links: PMID: 16157820 | DOI länk][Source: PubMed®]
9. Should the MTHFR 1298A>C polymorphism be considered in the clinical evaluation of patients at risk for thrombotic disease?

   Zetterberg Henrik.

   Genet Med. 2005:7(9):655.

   [Links: PMID: 16301870][Source: PubMed®]

   Web of Science® citations 0
10. Oetiskt av höga boxningsledare att inte ta säkerheten på allvar.

    Zetterberg H, Blennow K, Wallin A.

    Dagens medicin 2006:45:1.

    [Source: User]
11. Plasma Abeta in Alzheimer's disease--up or down?

    Zetterberg Henrik, Blennow Kaj.

    Lancet Neurol 2006:5(8):638-9.

    [Links: PMID: 16857565 | DOI länk][Source: PubMed®]

    Web of Science® citations 17
12. Re: "The inconsistency of 'optimal' cutpoints obtained using two criteria based on the receiver operating characteristic curve".

    Zetterberg Henrik.

    Am J Epidemiol. 2006:164(7):707-8; author reply .

    [Links: PMID: 16916984 | DOI länk][Source: PubMed®]

    Web of Science® citations 1
13. Aspects of β-amyloid as a biomarker for Alzheimer’s disease.

    Blennow Kaj, Zetterberg Henrik, Andreasson Ulf, Andersson Malin E, Portelius Erik.

    Biomarkers in Medicine 2007:1(1):20.

    [Links: DOI länk][Source: User]

    Web of Science® citations 34
14. Update on Alzheimer's and Parkinson's diseases.

    Zetterberg Henrik, Andreasson Ulf.

    Aging Health 2007:3

    [Source: User]
15. [Guidelines for brain concussion in sports--how are they to be applied in boxing?]

    Zetterberg Henrik, Hietala Max Albert, Wallin Anders, Blennow Kaj.

    Lakartidningen 2007:104(22):1715; author reply 1.

    [Links: PMID: 17601324][Source: PubMed®]
16. Biomarkers reflecting different facets of Alzheimer's disease.

    Zetterberg H.

    Eur J Neurol. 2008:15(11):1143-4.

    [Links: PMID: 18973609 | DOI länk][Source: PubMed®]

    Web of Science® citations 4
17. Additional evidence for antagonistic pleiotropic effects of APOE.

    Zetterberg Henrik, Alexander David M, Spandidos Demetrios A, Blennow Kaj.

    Alzheimer's & dementia : the journal of the Alzheimer's Association 2009:5(1):75.

    [Links: PMID: 19118812 | DOI länk][Source: PubMed®]

    Web of Science® citations 2
18. CSF antithrombin III and disruption of the blood-brain barrier.

    Zetterberg Henrik, Andreasson Ulf, Blennow Kaj.

    J Clin Oncol. 2009:27(13):2302-3; author reply.

    [Links: PMID: 19332721 | DOI länk][Source: PubMed®]

    Web of Science® citations 3
19. Alzheimer's disease and CSF biomarkers: key challenges for broad clinical applications.

    Mattsson Niklas, Zetterberg Henrik.

    Biomark Med 2009:3(6):735-7.

    [Links: PMID: 20477711 | DOI länk][Source: PubMed®]

    Web of Science® citations 3
20. Is it time for biomarker-based diagnostic criteria for prodromal Alzheimer's disease?

    Blennow Kaj, Zetterberg Henrik.

    Alzheimers Res Ther 2010:2(2):8.

    [Links: PMID: 20441609 | DOI länk][Source: PubMed®]
21. Pathognomonic cerebrospinal fluid findings in Bing-Neel syndrome.

    Zetterberg Henrik.

    J Neurooncol. 2011:104(2):615.

    [Links: PMID: 21221713 | DOI länk][Source: PubMed]
22. Zebrafish physiology: big interest in a small fish.

    Zetterberg Henrik.

    Acta Physiol (Oxf) 2011:201(3):295-6.

    [Links: PMID: 21281452 | DOI länk][Source: PubMed]

    Web of Science® citations 1
23. Increased levels of total tau protein in the cerebrospinal fluid in Huntington's disease.

    Constantinescu Radu, Romer Megan, Zetterberg Henrik, Rosengren Lars, Kieburtz Karl.

    Parkinsonism & related disorders 2011

    [Links: PMID: 21733739 | DOI länk][Source: PubMed®]
24. New diagnostic criteria for Alzheimer's disease.

    Zetterberg Henrik.

    Biomark Med 2011:5(4):407-9.

    [Links: PMID: 21861660 | DOI länk][Source: PubMed]

    Web of Science® citations 0
25. Pregnancy and a rare MTHFR haplotype.

    Parén Lisa, Palmqvist Lars, Barkhordar Giti Shah, Hellgren Margareta, Zetterberg Henrik.

    Acta obstetricia et gynecologica Scandinavica 2012

    [Links: PMID: 22360438 | DOI länk][Source: PubMed]

Article - Other (2)

1. Pinpointing plaques with PIB.

   Blennow Kaj, Zetterberg Henrik.

   Nat Med. 2006:12(7):753-4; discussion 75.

   [Links: PMID: 16829927 | DOI länk][Source: PubMed®]

   Web of Science® citations 11
2. The N-terminal domain of α-dystroglycan is released as a 38 kDa protein and is significantly increased in cerebrospinal fluid from patients with Lyme disease.

   Hesse Camilla, Johansson Inger, Mattson Niklas, Bremell Daniel, Andreasson Ulf, Halim Adnan, Anckarsäter Rolf, Blennow Kaj, Anckarsäter Henrik, Zetterberg Henrik, Larson Göran, Hagberg Lars, Grahn Ammi.

   Manuscript in preparation 2011

   [Source: User]

   Web of Science® citations 1

Accepterade men ännu ej publicerade publikationer

Arbetsgivare	Anställningsgrad		Började	Slutade
Statligt - Universitet - Göteborgs universitet - Sahlgrenska akademin - Institutionen för laboratoriemedicin [1991 - 2005]		100%	1999	2003
Statligt - Universitet - Göteborgs universitet - Sahlgrenska akademin - Institutionen för klinisk neurovetenskap, Utbildningssektionen [1991 - 2005]		100%	2003	2005
Statligt - Universitet - Göteborgs universitet - Sahlgrenska akademin - Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi [2006 - ]		70%	2006
Landsting - Västra Götalandsregionen - Specialiserad vård - Sahlgrenska Universitetssjukhuset, Område 4 - Laboratoriemedicin - Klinisk kemi		30%	2006

Docent i neurokemi.Läkarexamen 1998.
Läkarlegitimation 1999.
PhD 2003.
Specialistläkare, klinisk kemi 2006.
Biträdande forskare 50% Institutionen för klinisk neurovetenskap från maj 2004-.
Post-doc vid Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Institutes of Medicine, Boston, MA, USA, 2004-09-01 till 2005-08-31.
Docent vid Sahlgrenska Akademin, maj 2007.
Överläkare, klinisk kemi 2008-.
Biträdande sektionschef, Sektionen för psykiatri och neurokemi, 2008-2009.
Sektionschef, Sektionen för psykiatri och neurokemi, 2009-.